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Abbreviations 
 
9-BBN 9-borabicyclo[3.3.1]borane 
Ac acetyl 
Ang angeloyl 
ATR attenuated total reflection 
Bn benzyl 
BSA N,O-bis(trimethylsilyl) acetamide 
Bu butyl 
Bz benzoyl 
Cp cyclopentadienyl 
CSA camphorsulfonic acid 
Cy cyclohexyl 
D -(-)-DIPT  D -(-)-diisopropyl tartrate 
DBU 1,8-diazabicyloundec-7-ene 
DCE 1,2-dichloroethane 
DCM dichlormethane 
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DIAD diisopropyl azodicarboxylate 
DIBAL-H diisobutylaluminum hydride 
DIPA diisopropylamine 
DIPEA N,N-diisopropylethylamine 
DMAP 4-dimethylaminopyridine 
DME dimethoxyethane 
DMP Dess-Martin periodinane 
DMS dimethyl sulfide 
DMSO dimethyl sulfoxide 
dppf 1,1′-Bis(diphenylphosphino)ferrocen 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
Et ethyl 
HMPA hexamethylphosphoramide 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectroscopy 
Hydrpr 3-hydroperoxy-2-methylene-butyryl 
iBu isobutyl 
IBX 2-iodoxybenzoic acid 
iPr isopropyl 
IR infrared 
LDA lithium diisopropylamide 
LHMDS lithium bis(trimethylsilyl)amide 
M molar (concentration) 
mCPBA meta-chloroperoxybenzoic acid 
Me methyl 
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Mes 2,4,6-trimethylphenyl 
MOM methoxy methyl 
MPLC medium pressure liquid chromatography 
Ms mesyl 
MTT  
 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide 
NCS N-chlorosuccinimide 
Nic nicotinoyl 
NMO N-methylmorpholine N-oxide 
PDC pyridinium dichromate 
PG protective group 
Ph phenyl 
PMB paramethoxybenzyl 
PPTS pyridinium para-toluenesulfonate 
Pr propyl 
Pyr pyridine 
RCM ring closing metathesis 
TASF tris(dimethylamino)sulfur (trimethylsilyl)difluoride 
TBAF tetrabutylammonium fluoride 
TBAI tetrabutylammonium iodide 
TBDPS tert-butyldiphenylsilyl 
TBS tert-butyldimethylsilyl 
tBu tert-butyl 
TES triethylsilyl 
THF tetrahydrofuran 
Tig tigloyl 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMS trimethylsilyl 
Tol toluene 
Ts para-toluenesulfonyl 
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1. General Part 
1.1 Introduction  
Euphorbiaceae are widely spread all over the world. Mainly they occur in tropical regions as 
the Indomalayan ecozone and the tropical regions of Central and South America. A smaller 
variety can be found in tropical Africa, but also more moderate climate zones are well known 
to be habitat of Euphorbiaceae as the Mediterranean Basin, the Middle East, South Africa 
and southern USA. 
Genus Euphorbia is only one of around 300 genera of Euphorbiaceae and contains more than 
2,100 species. It is believed to be one of the most diverse genera in the whole plant 
kingdom.1 Some of these species have been used in many cultures to treat constipation, 
remove warts, heal breast ailments or as general tonic. For instance Euphorbia pithyusa, a 
species endemic to the central and western Mediterranean region, is known as medical plant 
since ancient times in Greece, the Roman Empire and later in medieval times.2-4 Another 
example is Euphorbia mongolica, endemic to southeastern parts of Asia, which is 
traditionally used to treat inflammation, warts and tumors.5 
 
Fig. 1 Carbon skeletones of Euphorbiaceae diterpenes. 
10 
 
When jatrophone (1) was isolated in 1970 from Jatropha gossypiifolia, which belongs to the 
Euphorbiaceae family, the interest of chemists began to grow, since this natural compound 
seemed to be one of the active compounds of the different traditional folk remedies in 
several countries.6-9  
The carbon skeleton of various diterpenes of the casbane, jatrophane, lathyrane, myrsinane, 
tigliane, ingenane, segetane, paraliane, pepluane and euphoractine families are shown in 
Fig. 1. Diterpenes that feature these skeletons are known as Euphorbiaceae diterpenoids.  
 
Fig. 2 Various jatrophane Euphorbiaceae diterpenes. 
The Euphorbiaceae diterpenes shown in Fig. 2 show a huge variety of functional groups and 
also differ in the oxygenation patterns. Due to the circumstance that they are diversely 
substituted with various acyl groups, such as acetyl, benzoyl, nicotinoyl or tigloyl, to name a 
few, the name “jatrophane polyesters” is also commonly used.10  
The skeleton of euphosalicin (2) and pepluanin A (3) differs from the common jatrophane 
skeleton. Structure elucidation of euphosalicin (2) led to an abeojatrophane skeleton, see 
Fig. 3, suggesting that one of the geminal methyl groups is incorporated in the ring which 
implicates a 13-membered macrocycle.11 
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Fig. 3 Jatrophane and abeojatrophane skeleton. 
Euphorbiaceae constituents have much to offer to researchers of different areas. 
Phytochemists are intrigued by the structural complexity of natural products obtained from 
these wide-spread plants. The high level of biological activity raises interest within the 
medicinal community, and last but not least, diterpenes isolated from plants of the 
Euphorbiaceae family offer a fascinating play-ground to synthetic chemists. The synthetic 
aspect becomes even more pronounced as insufficient quantities of diterpenes are available 
from natural sources for extensive biological evaluation.12-15 
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1.2 Aim of the Synthetic Work 
The goal of the present master thesis was the preparation of highly oxygenated five-
membered ring synthons, namely 16-19 shown in Fig. 4, required for the preparation of 
various jatrophane diterpenes such as ep-7 (4), eup-10 (6), euphosalicin (2) or pepluanin A 
(3), shown in Fig. 2. The strategy was based on previous studies by Lentsch and Rinner16 as 
described in section 1.4.1.5 of this document. The highly flexible route gives access to both 
high oxygenated patterns. Compounds 16-19 were envisaged to be synthesized based on the 
same methodology in a stereoselective manner. 
 
Fig. 4 Natural substitution patterns and their synthetic equivalents. 
The retrosynthetic analysis is discussed in detail in chapter 2.1 of this document. The 
envisaged key steps in the preparation of the five-membered ring synthon (16) were a 
Sharpless asymmetric epoxidation reaction17, a stereoselective aldol reaction18, a ring closing 
metathesis and a hydroboration/oxidation sequence16. 
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1.3 Isolation and Biological Activities of Jatrophane Diterpenes 
In 1970, Kupchan et al. isolated jatrophone (1) from Jatropha gossypiifolia and the carbon 
skeleton was named “jatrophane skeleton” after its botanical origin.8 After the isolation of 
jatrophone (1) only 4 more diterpenes with jatrophane skeleton (Fig. 5) were isolated from 
the genus Jatropha. 2α-Hydroxyjatrophone (20), 2β-hydroxyjatrophone (21), 2β-hydroxy-
5,6-isojatrophone (22) were isolated by Taylor et al. 1983, and japodagrone (23) was isolated 
from Jatropha podagrica by Aiyelaagbe et al. in 2007.19,20  
 
Fig. 5 Jatrophanes isolated from the genus Jatropha. 
Table 1 Antineoplastic activity of jatrophone and derivatives.
19
 
  
P-388 KB 
no. name in vivo [T/c], [mg/kg] ED50 [µg/mL] 
in vitro ED50, 
[µg/mL] 
1 jatrophone 145, 12.0 0.01 0.000087 
20 2α-hydroxyjatrophone 125, 6.0 0.03 0.16 
21 2β-hydroxyjatrophone 132, 10.0 0.06 0.07 
22 2β-hydroxy-5,6-isojatrophone no activity 2.2 0.03 
 
The isolation of jatrophone (1) is best described by Kupchan et al. (1976).7 Dried ground 
roots of Jatropha gossypiifolia L. (11.7 kg) were extracted continuously with hot ethanol. The 
dark brown gum received after evaporation of the solvent was triturated with benzene. The 
benzene fraction was evaporated and triturated with hexane. Treatment of the hexane 
fraction with activated carbon gave a light yellow oil from which jatrophone (1, 1.37 g, 
0.012%) was isolated after two chromatographic steps. 
Another isolation of jatrophone (1) from J. gossypiifolia was reported by Taylor et al., along 
with three new hydroxyjatrophanes 20-22.19 After Kupchan showed that jatrophone (1) was 
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soluble in hexane, Taylor reasoned that a preliminary fractionation with hexane, followed by 
chloroform would obtain jatrophone (1) and related compounds.7,8,19 
Starting from 25 kg dried and milled roots of J. gossypiifolia, several chromatographical steps 
were needed to isolate jatrophone (1, 2.31 g, 0.009%) and the two hydroxyjatrophanes (21, 
as colorless gum, 0.14 g, 0.0005%; and 22, as white crystals, 0.048 g, 0.0002%).  
From the CHCl3 fraction hydroxyjatrophane (20, 0.095 g, 0.001%) was obtained as colorless 
gum after five chromatographic steps. These compounds were tested for their antineoplastic 
activity in P-388 and the Eagle’s carcinoma of the nasopharynx test system (KB). The results 
of these tests are shown in Table 1.19 
Japodagrone (23) showed activity in standard disk assays against Bacillus subtilis (ATCC 6051) 
giving a zone of 12 mm at 20 µg/disk., whereas no activity against Staphylococcus aureus 
was observed.20 
A review published by Shi et al. in 2008 provides a good overview about the Euphorbiaceae 
diterpenes isolated from the genus Euphorbia.10 In this article, 154 Euphorbiaceae 
diterpenes possessing the jatrophane skeleton are listed. In comparison to the 5 jatrophanes 
isolated from the name giving genus Jatropha, Euphorbia seems to be a much more 
important source of jatrophanes. 
Within the following section of this master thesis, all newly isolated jatrophane diterpenes 
are listed, along with compounds which have not been discussed in Shi’s review article. 
 
Fig. 6 Jatrophanes isolated by Barile et al. 
Euphoscopin M (24), euphoscopin N (25) and euphornin L (26), shown in Fig. 6, were isolated 
by Barile et al. in 2008 from an ethyl acetate extract of E. helioscopia using a combination of 
chromatographic techniques (MPLC and HPLC). Euphoscopin M (24) and euphoscopin N (25) 
were found to inhibit P-glycoprotein-mediated mitoxantrone efflux. 21 
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Fig. 7 Jatrophanes isolated by Chen et al. and Duarte et al., respectively. 
Chen et al. reported the isolation of kansuinin D1 (27),see Fig. 7, from E. kansui in 2008.22 
Tuckeyanol A (28), tuckeyanol B (29) and euphotuckeyanol (30), also shown in Fig. 7, were 
isolated from E. tuckeyana by Duarte et. al.23 
The isolation of 7β,9α,14β-triacetoxy-3β-benzoyloxy-12β,15β-epoxy-11-hydroxyjatropha-5E-
ene (31) was reported by Lu et al. in 2008 (Fig. 8). The natural product (31) did not express 
cytotoxic activity against HeLa (human cervical carcinoma cells) and MDA-MB-231 (breast 
tumor cells). 31 was isolated along with known jatrophanes from an ethanolic extract of E. 
helioscopia after multiple chromatographic steps.24 Two years later, in 2010, Geng et al. 
reported the isolation of another jatrophane diterpene, shown in Fig. 8, named euphornin N 
(32), from E. helioscopia.25 
 
Fig. 8 Newly isolated jatrophanes from E. helioscopia by Lu and Geng, respectively. 
In 2010 Huang et al. reported the isolation of nine novel jatrophane diterpenes, shown in 
Fig. 9 and Table 2, from E. sororia in two independent papers.26,27 The structure of the 
sororianolides (39-41), which is called 17-bishomojatrophane, is remarkable, because of the 
8-membered lactone ring and the unusual substituents at C-1. Remarkably, compounds 33–
38 are reported with a cis-bicyclo[10.3.0]pentadecane skeletone, whereas usually a trans-
fused-bicyclo[10.3.0]pentadecane skeleton is found in jatrophane diterpenes. 
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Fig. 9 Jatrophanes and bishomojatrophanes from E. sororia. 
 
Table 2 Jatrophanes and bishomojatrophanes from E. sororia. 
no. name R
1
 R
2
 ref 
33 2α,7α-diisobutyroyloxy-3α-nicotinoyloxy-5β,8α,9α,15β- Nic Me 24 
 
tetraactoxyjatropha -6(17),11E-diene-14-one 
   34 2α-isobutyroyloxy-3α-nicotinoyloxy-5β,7α,8α,9α,15β- Nic iPr 24 
 
pentaactoxyjatropha-6(17),11E-diene-14-one 
   35 3α-benzoyloxy-2α,7α-diisobutyroyloxy-5β,8α,9α,15β- Bz iPr 24 
 
tetraactoxyjatropha-6(17),11E-diene-14-one 
   36 3α-benzoyloxy-2α-isobutyroyloxy-5β,7α,8α,9α,15β- Bz Me 24 
 
pentaactoxyjatropha-6(17),11E-diene-14-one 
   37 
3α-benzoyloxy-5β,14β-dihydroxy-2α-isobutyroyloxy-
7α,8α,9α,15β- 
- - 24 
 
tetraactoxyjatropha-6(17),11E-diene 
   38 
14β-benzoyloxy-2α,7β-diisobutyroyloxy-15α-hydroxy-
3β,5α,8α,9α- 
- - 24 
 
tetraactoxyjatropha-6(17),11E-diene 
   39 sororianolide A - - 25 
40 sororianolide B - - 25 
41 sororianolide C - - 25 
 
Euphopeplin A (42) was isolated by Song et al. in 2010 from E. peplus together with two 
already known compunds.28 Hegazy and co-workers isolated guyonianins E (43) and F (44) 
after repetitive chromatographic steps of the dichlormethane/methanol extract of E. 
guyoniana. Guyonianins E (43) and F (44) showed a moderate activity (IC50 = 70 and 100 µM, 
respectively) against human embryonic kidney cells (HKE293) in a test for their cytotoxic 
activities.29 Their structures and the structure of euphopeplin A (42) are shown in Fig. 10. 
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Fig. 10 Euphopeplin A (42) and guyonianins E (43) & F (44). 
Aljancic et al. isolated six jatrophanes (euphodendrines A-F, 45-50, see Fig. 11) from the 
Montenegrin spurge E. dendroides in 2011.30 The euphodendrines A,B,D and E (45, 46, 48, 
49,) only differ in the ester functionalities, euphodendrine C (47) is the only one of these 
compounds that has no alcohol moiety, whereas euphodendrine F (50) has no exocyclic but 
a second endocyclic double bond. Fig. 11 and Table 3 show the structures of the newly 
isolated compounds and selected data of their biological evaluation.30 
 
Fig. 11 Euphodendrines A-F (45-50). 
Table 3 Euphodendrines A-F (45-50) and their growth inhibitory effects on different cancer cell lines. 
no. name R
1
 R
2
 R
3
 R
4
 R
5
 R
6
 NCI-H460* NCI-H461* DLD-1* U-87 MG* 
45 euphodendrine A Et Ac iPr Ac Nic H 46.6 44.8 59.3 155.3 
46 euphodendrine B iPr Ac iPr Ac Nic H 16.2 17.2 22.1 107.7 
47 euphodendrine C Et Ac iPr Ac Nic Ac - - - - 
48 euphodendrine D iPr Ac Me Bz Ac H 21.3 30.1 42.7 52.6 
49 euphodendrine E Et Ac iPr Bz Ac H 21.9 49.8 37.9 73.1 
50 euphodendrine F - - - - - - 14.8 90.8 75.3 65.5 
* The values presented here are IC50 [µM] 
 
Jatrophanes 51 and 52 (Fig. 12) were isolated in Iran by Shokoohinia et al. in 2011.31 Several 
chromatographic steps were needed to yield compounds 51 and 52 from an acetone extract 
of E. bungei Boiss. 
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Fig. 12 Jatrophanes isolated by Shokoohinia et al. 
After the isolation of esulatins A-F by Hohmann et al., the same workgroup also reported the 
isolation of esulatin H-M (53-58), shown in Fig. 13.32-36 Esulatins A-M were isolated from E. 
esula, as the name suggests. Esulatin G has a norparaliane skeleton,37 whereas all the 
esulatins isolated by Hohmann and co-workers possess a jatrophane skeleton. 
A set of human adherent cell lines of gynecological origin (HeLa, Ishikawa and MCF7) was 
used to test the esulatins isolated by Hohmann et al. for their antiproliferative activity using 
the MTT test38. Esulatin J (55) showed the highest activity of all tested compounds against all 
cell lines (HeLa 64.5 at 30 µg/mL, Ishikawa 98.4% at 30 µg/mL and MCF7 81.4% at 30 µg/mL). 
Esulatin I (54) and esulatin B (8) were also notably active against the cell growth of MCF7 
(60.1% and 43.3% at 30 µg/mL each). The highest MDR-reversing activity in L5178 mouse 
lymphoma cells was found for esulatin J (55) and esulatin M (58). The activities were found 
to be two- and five-fold higher than verapamil, which was used as positive control in the 
tests.32 
 
Fig. 13 Esulatins H-M (53-58). 
Diterpenes possessing the jatrophane skeleton have also been isolated from other sources 
than Jatropha or Euphorbia, several novel compounds, isolated from Pedilanthus 
19 
 
tithymaloides, are outlined in Fig. 14. Compounds (59 - 63) were tested for antimalarial and 
antitubercularial effects against Plasmodium falciparum K1 strain and Mycobacterium 
tuberculosis H37Ra, respectively. Compounds 59, and 61 - 63 were found to possess an 
antimalarial effect with LC50 values of 3.4 - 4.4 µg/mL. The antitubercularial effects were less 
pronounced, 59 was most active with 12.5 µg/mL minimum inhibitory concentration. 
Compounds 59, 60 and 63 showed no activity in an additional antifungal assay against 
Candida albicans at 50 µg/mL.39 
 
Fig. 14 Jatrophanes isolated from P. tithymaloides. 
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1.4 Previously Reported Synthetic Studies on Euphorbiaceae Diterpenes 
1.4.1 Syntheses of Five-Membered Ring Synthons 
1.4.1.1 Yamamura’s Cyclopentane Derivative 
Yamamura et al. investigated the syntheses of Euphorbiaceae diterpenes and their 
biomimetic conversion. A simplified retrosynthetic analysis of Euphorbiaceae diterpenes is 
shown in Scheme 1.40 
 
Scheme 1 Proposed application of Yamamura’s cyclopentane derivative. 
Scheme 2 shows the preparation of Yamamura’s cyclopentane fragment (66). Silylation of 
literature known alcohol 6841 was followed by dihydroxylation of the double bond with 
osmium tetroxide. The resulting diol was proteceted to give benzylidene acetal 69. After 
saponification of the acetyl group, mesylation of the resulting alcohol, deprotecion of the 
TBS group and subsequent oxidation of the free secondary alcohol, enone 70 was obtained. 
After conjugate addition of a methyl group the carbonyl moiety was reduced and benzylated 
to give 71. Removal of the benzylidene acetal afforded a vicinal diol, selective TBS protection 
of the sterically less hindered hydroxy group led to a secondary alcohol which was then 
converted into a ketone (72) by a Swern oxidation. Next, Petasis methylenation and 
hydroboration led to the corresponding primary alcohol. 73 was obtained after desilylation 
and protection of the resulting diol as acetonide. Cleavage of the benzyl group via Birch 
reaction and oxidation of the alcohol under Swern conditions afforded ketone 74. 
Nucleophilic addition of 1-propinylmagnesium bromide to the carbonyl function gave 
diastereomers 75a and 75b. Treatment of the main product (75a) with TsNCO furnished the 
desired cyclopentane segment 66 on a gram scale via cyclic intermediate 76. 
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Scheme 2 Preparation of Yamamura’s cyclopentane fragment (66). 
1.4.1.2 Hiersemann’s Cyclopentane Building Block 
Helmboldt and Hiersemann reported a synthesis of a five-membered ring fragment of 
jatrophane diterpenes in 2003.42 The key steps of their synthesis, shown in Scheme 3, are a 
Horner-Wadsworth-Emmons olefination and a carbonyl-ene reaction which led them to 
cyclopentane derivative 78a. The diastereoselectivity of the carbonyl-ene reaction was 
expected to be more favorable for their desired product if the configuration of the C-3 
stereocenter was R, whereas the configuration of the C-3 atom in natural products is S. 
Therefore, this stereogenic center has to be inverted in total syntheses of jatrophane 
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diterpenes. Certainly, a larger number of steps in total syntheses are necessary for this 
inversion but better yields in the synthesis of the cyclopentane fragment can be obtained in 
return. 
Scheme 3 Retrosynthetic analysis of Hiersemann’s cyclopentane fragment. 
Scheme 4 outlines the first part of the synthesis of 78a in detail. The synthesis of the five-
membered ring synthon was improved and 78a was applied to the preparation of the 
norjatrophane diterpene (-)-15-acetyl-3-propionyl-17-norcharaciol (81) by Hiersemann.43 
Evan’s aldol reaction of 81 with crotonaldehyde delivered β-hydroxyester 82 after cleavage 
of the auxiliary with sodium methoxide. Protection of the alcohol moiety was followed by a 
reduction-oxidation sequence to give aldehyde 80. Horner-Wadsworth-Emmons reaction of 
phosphonoacetate 83 and aldehyde 80 gave 84, which delivered α-keto ester 79 under basic 
conditions. 
 
Scheme 4 Synthesis of the cyclopentane fragment by Hiersemann - part 1. 
As shown in Scheme 5, the carbonyl-ene reaction of 79 yielded the desired diastereomer 78a 
in good yield. The side product 78b could be converted in a mixture of both diastereomers 
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(78a/78b=5/1) again via a retro-ene/ene reaction under similar conditions as the original 
carbonyl-ene reaction. Recycling was reported with 180°C in decane and several days 
reaction time.42 
 
Scheme 5 Synthesis of the cyclopentane fragment by Hiersemann - part 2. 
 
1.4.1.3 Mulzer’s Cyclopentane Fragment 
Mulzer reported the synthesis of a highly oxygenated cyclopentane synthon 85 for the total 
synthesis of jatrophane diterpenes.44,45 Scheme 6 shows the retrosynthetic analysis which 
goes back to known alcohol 87.46 
 
Scheme 6 Mulzer’s retrosynthetic analysis. 
 
Scheme 7 Peparation of tertiary alcohol 87. 
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An alternative preparation of alcohol 87, shown in Scheme 7, was also presented. Furfuryl 
alcohol 88 was converted into a separable mixture of acetate 90 and alcohol 91 using a 
protocol reported by Curran et al.47 These compounds were converted in a common 
intermediate, ketone 93, using established chemistry.48 Alcohol 87 was obtained by 
nucleophilic addition of methyl lithium.46 The starting material (68) of the preparation of 
Yamamura’s cyclopentane40 can also be prepared in this fashion. 
 
Scheme 8 Synthesis of Mulzer’s cyclopentanyl vinyl triflate 85. 
The following steps are shown in Scheme 8. Amide 94 was obtained from tertiary alcohol 87, 
by a Claisen-Eschenmoser rearrangement. In the next step an epoxide was formed, which 
spontaneously yielded the requisite bicyclic lactone via intramolecular opening of the 
oxirane moiety with the newly installed amide during flash chromatography. The resulting 
tertiary alcohol was then protected as MOM ether 95. Cleavage of the silyl ether directly 
gave the desired rearranged lactone. The resulting alcohol was protected as MOM ether (86) 
as well. Davis’ oxidation gave the desired alcohol 96, which was protected as PMB ether in 
the next step. Treatment of 97 with pyrrolidine yielded amide 98. The free hydroxy group 
was TES protected before the amide group was converted to the corresponding methyl 
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ketone 99. Kinetically controlled deprotonation and addition of PhNTf2 to the reaction 
mixture finally afforded the desired synthon 85. 
 
1.4.1.4 Uemura’s Cyclopentane Segment 
The synthesis of cyclopentane segment 102 was reported by Shimokawa, Takamura and 
Uemura in 2007.49 As shown in Scheme 9, Uemura et al. envisaged the construction of the 
macrocycle of kansuinine A (100) via two NHK coupling reactions as key steps. Following 
their retrosynthetic rationale, the exocyclic double bond should be constructed via coupling 
of the C-5 aldehyde in cyclopentane-segment 102 with the requisite vinyl halide while final 
ring closing reaction should become feasible via reaction of TMS-alkyne derived vinyl halide 
with the corresponding aldehyde.  
 
Scheme 9 Retrosynthetic analysis of kansuinine A (100). 
The synthesis, shown in Scheme 10, starts with Mukaiyama aldol reaction of 
trimethylsilylketene ethyl trimethylsilyl acetal and aldehyde 10450,51, derived from β-
hydroxyester 103,50,51 and sequential desilylation to give β-hydroxyester 105. Diol 106 was 
obtained by treatment of 105 with LDA and a formaldehyde solution. After protection of the 
diol as acetonide, anti- and syn-107 were separable by chromatography. Cleavage of the 
benzyl group and iodination under Appel conditions led to iodoester 108. A variety of 
reaction conditions were tried for the intramolecular SmI2-mediated nucleophilic acyl 
substitution. Intermediate 109 was obtained with 86% yield as best reported result. 
Noteworthy, protective groups other than the isopropylidene group or reaction of the 
unprotected diol tended to deliver protonated acyclic species as well as the cyclopentanes. 
Next, Grignard reaction of trimethylsilylethynylmagnesium bromide and cyclopentanone 109 
gave tertiary alcohol 110 as single stereoisomer. Acid mediated deprotection and 
subsequent selective TBS protection of the primary alcohol delivered 111 before acetylation 
of the secondary alcohol and selective deprotection of the TBS group led to primary alcohol 
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112. The preparation of the cyclopentane segment (102) was concluded by Dess-Martin 
oxidation of the requisite alcohol. 
 
Scheme 10 Synthesis of Uemura’s cyclopentane segment 102. 
1.4.1.5 General Cyclopentane Segments of Lentsch and Rinner 
The retrosynthesis of a cyclopentane segment (15) reported by Lentsch and Rinner is shown 
in Scheme 11.16 The corresponding diastereomer with inverted configuration at C-2 (14) was 
also accessed via the same route. However, as the synthesis of this material is identical to 
the route towards 15, further discussion is omitted at this point. 
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Scheme 11 Retrosynthesis of the cyclopentane segments by Lentsch and Rinner. 
Alcohol 115 was obtained by Myers’ alkylation of the corresponding pseudoephedrine 
propionamide with allyl iodide, followed by a lithium aminoborohydride reduction.52 As 
shown in Scheme 12, oxidation of alcohol 115 with IBX gave aldehyde 116. Stereoselective 
aldol reaction with (R)-HYTRA afforded 117 in a diasteriomeric ratio of at least 10:1 (ratio 
was determined by NMR analysis after transformation to the methyl ester 118). The 
introduction of an exomethylene group was achieved via aldol reaction of 118 with 
formaldehyde, tosylation of the primary alcohol, and subsequent DBU-mediated elimination. 
Next, TBDPS protection of the remaining secondary hydroxy group afforded 120. The ester 
function was reduced to the primary alcohol using DIBAL-H, and the primary hydroxy moiety 
was protected with PMB-Bundles reagent. Ring closing metathesis, mediated by Grubbs II 
catalyst, gave cyclopentene 122. A hydroboration/oxidation sequence delivered 
cyclopentanone 15. 
 
Scheme 12 Preparation of cyclopentane fragment 15 by Lentsch and Rinner. 
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1.4.2 Total Syntheses of Jatrophane Diterpenes 
1.4.2.1 Total Synthesis of (±) Normethyljatrophone by Smith et al. 1981 
With the synthesis of 123, Smith et al. were the first to complete a total synthesis of a 
jatrophane diterpene.12 The strategy, see Scheme 13, relied on a general method for the 
construction of a 3-(2H)-furanone ring system they had developed in the first place. Later, a 
Mukaiyama aldol reaction closes the macrocyclic ring before the conversion of acetylene 
(124) to a trans-fused double bond concludes the synthesis of normethyljatrophone (123). 
 
Scheme 13 Retrosynthetic analysis of normethyljatrophone (123). 
 
Scheme 14 Smith’s cyclopentene building block. 
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Ketone (126) was built from α-hydroxymethylcyclopentenone (128), as outlined in Scheme 
14.53,54 Silylation of 128 was followed by treatment with lithiodithiane (130) and gave 131, 
which was then hydrolyzed to give ketone 132. Cleavage of the TBS group and subsequent 
TMS protection of both free hydroxy groups delivered desired ketone 126 with an overall 
yield of 42%. 
As shown in Scheme 15, aldehyde (127) was prepared from 3,3-dimethyl-4-pentynoic acid 
(133). The hydroxy acid (134) was obtained by treatment of the dianion of 133 with 
propanal. TBS protection led to 135, which was reduced with lithium aluminum hydride to 
give the primary alcohol 136. Treatment with Collins’ reagent55 gave aldehyde 127 in 55% 
yield over 4 steps. Following the protocol to construct the spirofuranone array which was 
developed prior to the synthesis, aldehyde 127 was added to the deprotonated ketone 126 
to give the β-hydroxy ketone 137. Spirofuranone (138) was obtained in an overall yield of 
68% after oxidation, acid catalyzed deprotection and cyclization/dehydration. Protection of 
the aldehyde as acetal and the oxidation of hydroxy group with Collins reagent55 gave ketone 
139. Direct aldol cyclization failed, but an attempt of Mukaiyama aldol reaction with the silyl 
enol ether and the acetal was successful and delivered 140 as major diastereomer. Both 
diastereomers were found to eliminate ethylene glycol upon treatment with p-
toluenesulfonic acid and gave 124 after sufficiently long reaction times. The long reaction 
time was necessary to achieve isomerization of the less stable E-isomer. In the final steps of 
this synthesis, the acetylene had to be converted into the trans olefin. A direct approach 
failed, probably due to transannular interactions, but selective cis hydrogenation led to 141, 
which could be isomerized to normethyljatrophone (123). In summary, the total synthesis of 
racemic normethyljatrophone (123) has been reported with an overall yield of 5.6% in 15 
steps starting from cyclopentenone (128). 
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Scheme 15 Synthesis of normethyljatrophone (123). 
1.4.2.2 Total Synthesis of (+)-Hydroxyjatrophone A and (+)-Hydroxyjatrophone B by 
Smith et al. 1989 
In close analogy to the earlier published total synthesis of normethyljatrophone,12 Smith et 
al. reported the total synthesis of the diastereomers (+)-hydroxyjatrophone A (20) and(+)-
hydroxyjatrophone B (21) in 1989.15 An intramolecular Mukaiyama acetal-aldol reaction was 
envisaged to construct the 11-membered macrocycle as key step, as shown in Scheme 16. 
The 3(2H)-spirofuranone was built up from acid-promoted cyclization. Early stage synthons 
are ketones 144a/144b and aldehyde 127 that are used in an aldol reaction to synthesize 
intermediates 143a and 143b.  
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Scheme 16 Retrosynthetic analysis of (+)-hydroxyjatrophone A (20) and (+)-hydroxyjatrophone B (21). 
 
Scheme 17 Synthesis of (+)-hydroxyjatrophone A (20) and (+)-hydroxyjatrophone B (21) – part 1. 
Racemic tertiary alcohol 145, which is available from 1,3-cyclopentenetione in three steps56, 
was treated with (+)-O-methylmandeloyl chloride (146) to give diastereomeric esters 147a 
and 147b, as shown in Scheme 17. After separation of the diastereomers by flash 
chromatography, the ester moiety in 147a was cleaved with aluminum hydride. From the 
resulting diol 148a the desired ketone (-)-149a was obtained after protection as triethyl silyl 
ether. (+)-149b was obtained from ester 147b in the same fashion in a yield of 63%, thus 
discussion within the scheme is omitted. 
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Scheme 18 Synthesis of (+)-hydroxyjatrophone A (20) and (+)-hydroxyjatrophone B (21) – part 2. 
Scheme 18 shows the synthesis of (+)-hydroxyjatrophone A (20) and (+)-hydroxyjatrophone 
B II (21). Addition of dithiane 130 to ketone 149b provides 150b in good yield and 
diastereomeric ratio. Hydrolysis of the dithiane moiety with mercury (II) perchlorate yields 
diol-ketone 151b. Protection leads to key intermediate 144b. After deprotonation and 
addition of the racemic aldehyde 127 that was already used in the synthesis of 
normethyljatrophone (123), a diastereomeric mixture of β-hydroxyketones 143b was 
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obtained. Treatment with Collins’ reagent gave enal-dione 152b. Acid promoted cyclization 
and desilylation led to the furanone array in 153b. Ketalization of 153b and subsequent 
oxidation gave advanced intermediate 142b, which reacts under the known Mukaiyama 
aldol conditions to give a diastereomeric mixture of products (154ba/154bb). The major 
diastereomer 154ba (R1=Me, R2=H) gave the corresponding trans olefin 155b after 
treatment with p-toluenesulfonyl chloride and DBU. However, the minor diastereomer 
154bb (R1=H, R2=Me) eliminated ethylene glycol efficiently under treatment with DBU to 
give 155b, without the prior conversion into a tosylate. Photoisomerization converted the 
trans double bond into a cis double bond (156b). The final step was hydrogenation of the 
alkyne and isomerization to the desired trans double bond in (+)-hydroxyjatrophone B (21).  
(+)-Hydroxyjatrophone A (20) was synthesized in a similar fashion with a slightly changed 
order of reactions. The C-2 TMS protected derivative of 149a was used instead of using the 
free hydroxy group in the lithio dithiane (130) addition step. Hydrolysis of the dithiane 
moiety followed by silylation of the tertiary alcohol leads to tris-protected triol 144a in 20% 
overall yield starting from 149a. The remaining steps are identical to the shown synthesis of 
(+)-hydroxyjatrophone B (21) shown in Scheme 18. 
1.4.2.3 Total Synthesis of (±)-epi-Jatrophone and (±)-Jatrophone by Hegedus et al. 
1990 
After Smith et al. synthesized racemic jatrophone, Hegedus et al. reported the total 
synthesis of racemic-epi-jatrophone (157) and racemic jatrophone (1) using palladium-
catalysis.13 Stille et al. developed a palladium-catalyzed carbon-carbon bond-forming process 
of vinylic triflates and organostannanes, the so called “Stille carbonylative cross-coupling”.57-
59 This technique was used in the final steps of the synthesis as shown in the retrosynthetic 
analysis (Scheme 19). 
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Scheme 19 Hegedus‘ retrosynthetic analysis of (±)-epi-jatrophone (157). 
3(2H)-spirofuranone 158b was accessible through acid-mediated cyclization dehydration as 
reported by Smith et al.12 Its precursor 1,3-diketone 159b was synthesized by aldol reaction 
of ketone 160a and vinyltin-bearing aldehyde 161.  
 
Scheme 20 Hegedus‘ synthesis of (±)-epi-jatrophane (157) - part 1. 
Conjugate addition of thiophene derived vinyltin 163 to ethyl 3,3-dimethylacrylate (162) 
afforded 164. Reduction of the ester with DIBAL-H provided the vinyltin bearing aldehyde 
161, as shown in Scheme 20. 
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Scheme 21 Hegedus‘ synthesis of (±)-epi-jatrophane (157) - part 2. 
The approach to compound 159b, shown in Scheme 21 started with a 
bromination/dehydrobromination sequence to afford 166.60,61 Ketalization provided 167, 
which was converted to the diastereomers 168 after halogen-metal exchange and addition 
of propylene oxide.62 Protection of the hydroxy group as a TBS ether gave 169, which was 
converted to α,β-unsaturated ketone 170 (16% yield for the overall sequence) under acidic 
conditions.  
Through addition of lithio-dithiane 130, a complex mixture of diastereomers (171) was 
obtained.63 The dithiane moiety was removed with mercury (II) chloride to give target 
molecule 172b and its stereoisomer 172a (47% for both steps, 1:9 ratio). The major product 
(diastereomer 172b) was used to synthesize (±)-epi-jatrophone (157), whereas the minor 
product 172a was used in the synthesis of (±)-jatrophone (1). The TBS ether was cleaved 
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with TBAF, the resulting diol 173b was protected as TMS ether 160b on both hydroxy groups. 
Intermediate 159b was accessible via an aldol reaction of ketone 160b and aldehyde 161. 
Scheme 22 shows further oxidation of hydroxyketone 159b which provided 1,3-diketone 
174b. The cyclization was accomplished via treatment of 174b with TASF, an anhydrous 
fluoride source. Because other approaches failed, it was necessary to conduct the cyclization 
under aprotic conditions. Conveniently this method also cleaved the other TMS ether, so 
oxidation of the secondary hydroxy group led to diketone 176b. This could be done without 
the need for another deprotection step. Conversion of the newly generated ketone into Z-
vinylic triflate gave key intermediate 158b. In the final step epi-jatrophane (157) was 
obtained by a reaction that is known today as Stille carbonylative cross-coupling.59 
 
Scheme 22 Hegedus‘ synthesis of (±)-epi-jatrophane (157) – part 3. 
(±)-Jatrophone (1) was synthesized following exactly the same route from the minor 
occurring diastereomer 172a after addition of dithiane 130. 
1.4.2.4 Total Synthesis of (+)-Jatrophone 1992 by Wiemer et al. 
In 1992, Han and Wiemer were the first to report an enantiopure synthesis of (+)-
jatrophone.14 The retrosynthetic analysis of (+)-jatrophone (1) is shown in Scheme 23. 
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Scheme 23 Wiemer’s retrosynthetic analysis of (+)-jatrophone (1). 
The synthesis of (+)-jatrophone (1) is shown in Scheme 24 in detail. (R)-Pulegone (180) was 
used as a chiral source in this synthesis as an optical pure starting material. Oxidation of the 
starting material with KMnO4 and subsequent esterification yielded 3-methyl diadipate 
(179).64 Regioisomers 181 and 182 were obtained after a Dieckmann condensation.65 
Separation of these regioisomers was postponed after the introduction of an α-hydroxy 
substituent.66 Both regioisomers 181 and 182 were converted to the corresponding silyl enol 
ethers 183 and 184. Diastereomers 185a and 185b were obtained by treatment of silyl enol 
ethers 183, which was left primarily unreacted, and 184 with OsO4 and NMO and removal of 
the undesired regioisomers. The next two steps provided triflates 186a and 186b, which is 
referred to as starting material in the publication that reports on the synthesis of (+)-
jatrophone (1).14 However, reaction of triflate 186b and diethyl ethylphosphonate gave β-
keto phosphonate 178.67 Acetylenic acid 133 was converted into the corresponding acid 
chloride, and was then reacted with β-keto phosphonate 178 in a FeCl3-catalyzed acylation 
reaction yielding intermediate 187. Furanone 188 was obtained through an intramolecular 
Horner-Wadsworth-Emmons reaction by treatment of 187 with NaH in DME. In previous 
studies Wiemer et al. investigated this method, whereas they originally expected better 
yields from treatment with K2CO3 than NaH.
68,69 Coupling of organostannane 189 and triflate 
188 and subsequent deprotection afforded advanced primary alcohol 177, which was 
oxidized to the corresponding aldehyde (190) in the next step using Swern conditions. 
Macrocyclization of acetylenic aldehyde 190 was accomplished by treatment with LHMDS 
under strictly anhydrous conditions. Subsequent Swern oxidation afforded acetylene 191, 
which was converted to optical active (+)-jatrophone (1) following Smith’s procedure for the 
reduction of ynone 191 to the natural product.12,15 Optical rotation of synthetic (+)-
jatrophone was +289°, nearly identical to natural (+)-jatrophone (+292°). Impurities of this 
grade were expected since (+)-pulegone (180, ee 98%) was used as starting material. 
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Scheme 24 Wiemer’s synthesis of (+)-jatrophone (1). 
1.4.2.5 Synthesis of the Norjatrophane Diterpene (-)-15-Acetyl-3-propionyl-17-
norcharaciol 
The report of the synthesis of the norjatrophane diterpene (-)-15-acetyl-3-propionyl-17-
norcharaciol (81) by Hiersemann et al. was the first application of his methodology to build a 
five membered ring synthon via an ene-reaction.42,43,70 The retrosynthetic analysis (Scheme 
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25) envisaged a late stage ring closing metathesis of 192. A Horner-Wadsworth-Emmons 
olefination of aldehyde 194 with β-keto phosphonate 193 afforded a precursor of the 
advanced intermediate 192, which was only accessible through an inversion of the 
stereocenter on C-3 on the synthetic path. β-Keto phosphonate 192 was derived from 
Hiersemann’s five-membered ring synthon 78a. 
 
Scheme 25 Retrosynthetic analysis of (-)-15-acetyl-3-propionyl-17-norcharaciol (81). 
 
Scheme 26 Synthesis of aldehyde 194. 
The synthesis of the five-membered ring synthon 78a was already shown in Scheme 4 and 
Scheme 5 (chapter 1.4.1.2), respectively. In Scheme 26 the synthesis of aldehyde 194 is 
shown in detail. TES protection of 2-iodo ethanol (195) gave silyl ether 196. Reaction with 
deprotonated ethyl isobutyrate, followed by reduction and subsequent Parikh-Doering 
oxidation afforded aldehyde 197. Addition of a Grignard reagent derived from iodine 199, 
which was obtained in moderate yield from but-3-en-1-ol (198), gave racemic secondary 
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alcohol 200. Protection gave disilyl ether 201, which was converted to aldehyde 194 by 
selective oxidation of the primary hydroxy group. 
Scheme 27 shows how the synthesis of (-)-15-acetyl-3-propionyl-17-norcharaciol (81) was 
concluded. By TMS protection of the free hydroxy group in the five-membered ring synthon 
78a and subsequent treatment with deprotonated diethyl ethylphosphonate β-keto 
phosphonate 193 was obtained. A Horner-Wadsworth-Emmons olefination of aldehyde 194 
provided 202. TBAF and PPTS removed the TMS and the TES groups, respectively. Oxidation 
of the secondary hydroxy group to the corresponding ketone and cleavage of the remaining 
TBS group afforded diketone-diol 203. Inversion of the stereocenter at C-3, which occurred 
in 3 steps by a Mitsunobu reaction and transesterification sequence, provided advanced 
intermediate 192. A ring closing metathesis mediated by Grubbs II catalyst (204) led to 
tertiary alcohol 205. Acetylation of the free hydroxy group in the final step yielded target 
molecule (-)-15-acetyl-3-propionyl-17-norcharaciol (81). 
 
Scheme 27 Synthesis of (-)-15-acetyl-3-propionyl-17-norcharaciol (81). 
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1.4.2.6 Synthesis of (-)-15-O-Acetyl-3-O-propionylcharaciol by Hiersemann et al. 
2009 
In 2009 Hiersemann et al. reported the total synthesis of (-)-15-O-Acetyl-3-O-
propionylcharaciol (206), a jatrophane diterpene originally isolated from Euphorbia 
characias.71,72 An earlier attempt using the same reactions as in the synthesis of (-)-15-
acetyl-3-propionyl-17-norcharaciol (81) was not successful.43 
 
Scheme 28 Retrosynthetic analysis of (-)-15-O-acetyl-3-O-propionylcharaciol (206). 
The retrosynthetic analysis (Scheme 28) shows that characiol (207) was envisaged as suitable 
advanced intermediate in this synthesis. Hiersemann’s five membered ring synthon (78a) 
was considered as precursor of this diol (207). 
Scheme 29 illustrates how selenide 208 was made. An in situ generated phenylselenide 
anion reacted with dibromide 209 and afforded 210. A subsequent alkylation of the anion of 
isobutyronitrile delivered nitrile 211. Reduction with DIBAL-H afforded aldehyde 212. Allylic 
alcohol 213 was obtained after addition of vinylmagnesium bromide to the aldehyde (212) 
generated before. Protection as PMB ether yielded intermediate 208. 
 
Scheme 29 Synthesis of (-)-15-O-acetyl-3-O-propionylcharaciol (206) – part 1. 
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Scheme 30 Synthesis of (-)-15-O-acetyl-3-O-propionylcharaciol (206) – part 2. 
Characiol (207) was synthesized as shown in Scheme 30. Hiersemann’s five-membered ring 
synthon (78a) was considered as advanced starting material. The synthesis of this fragment 
is shown, as pointed out above, in Scheme 4 and Scheme 5 (chapter 1.4.1.2), respectively. 
Reduction of the starting material (78a), gave a vicinal diol, which was protected with an 
isopropylidene moiety. Ozonolysis of the double bond with reductive workup gave aldehyde 
214. Aldehyde 214 was converted to alkyne 215 in two steps. Hydrozirconation of the alkyne 
gave vinyl iodide 216 as single isomer. B-alkyl Suzuki-Miyaura cross-coupling of 208 and 216 
provided 217 as mixture of diastereomers. The installation of the double bond via 
oxidation/elimination of phenyl selenide was followed by removal of the isopropylidene 
moiety (lanthanum(III) nitrate hexahydrate was found not to affect the other protecting 
groups in the molecule), before the resulting primary alcohol was oxidized to aldehyde 218. 
Addition of isopropenyl lithium, cleavage of the PMB ether and subsequent oxidation of the 
newly generated secondary alcohol groups delivered corresponding diketone 219. RCM 
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mediated by Grubbs II catalyst (204) and a deprotection step gave diol 220. Inversion of the 
C-3 stereocenter gave characiol (207) in two steps. 
Regioselective esterifications of the jatrophone core (Scheme 31) proved that the original 
assignment by Seip and Hecker72 of (-)-15-O-acetyl-3-O-propionylcharaciol (206) was correct. 
With the preparation of 206, Hiersemann et al. were the first to synthesize a jatrophane 
diterpene isolated of the genus Euphorbia in enantioselective fashion. 
 
Scheme 31 Synthesis of (-)-15-O-acetyl-3-O-propionylcharaciol (206) - part 3. 
1.4.2.7 Total Synthesis of Natural and Non-Natural Δ5,6Δ12,13-Jatrophane 
Diterpenes by Hiersemann et al. 2011 
Building on prior syntheses, Hiersemann et al. reported the synthesis of natural 15-O-acetyl-
3-O-benzoylcharaciol (5R, 6R)-oxide (224) as well as a collection of non-natural jatropha-
5,12,-dienes.73 Scheme 32 outlines how 15-O-acetyl-3-O-benzoylcharaciol (5R, 6R)-oxide 
(224) was available from previously reported diol 22071 in three steps. There had been 
controversial statements about the configuration of the epoxide moiety by Uemura, who 
proposed a (5R, 6R) configuration74, and Seip and Hecker who depicted a (5S, 6S) 
configuration72 in this natural compound. Hiersemann et al. agreed to Uemuras assignment 
which was validated in two independent NOE studies.75,76  
A total of 18 synthetic natural and non-natural jatrophane diterpenes, some examples are 
depicted in Scheme 32 and Scheme 33, were tested concerning their MDR modulating 
activity. 228 was found to possess an inhibitory potency comparable to that of standard 
inhibitor verapamil towards ABCB1 (p-glycoprotein).73,77 Inhibitory activity of the same 
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compound was also found against ABCG2. Similar compounds with lipophilic residues were 
also found to be active against ABCB1. 
 
Scheme 32 Synthesis of 15-O-acetyl-3-O-benzoylcharaciol (5R, 6R)-oxide (224) and non-natural jatrophane 
diterpenes by Hiersemann et al. – part 1. 
 
Scheme 33 Synthesis of non-natural jatrophane diterpenes by Hiersemann et al. - part 2. 
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2. Results and Discussion 
2.1 Retrosynthethic Analysis 
 
Scheme 34 Synthetic equivalents to highly oxygenated five-membered rings in jatrophane diterpenes. 
As outlined in the introduction (chapter 1.2) the preparation of synthons 16–19 (Scheme 34) 
was considered as goal of this master thesis.  
  
Scheme 35 Initial retrosynthetic analysis. 
Scheme 35 shows the proposed retrosynthetic analysis of synthon 16. It contains several 
steps that are envisaged in close analogy to previous work done in our laboratory, described 
in detail in chapter 1.4.1.5 of this document.16 We considered five-membered ring synthon 
16 as possible precursor to a variety of natural products (234), since the epoxide can be 
opened to deliver the desired C-2 pattern. The ketone functionality in 16 can be used in a 
vast number of C-C bond forming reactions, for instance a pinacol coupling reaction, and the 
primary hydroxy group, here protected as PMB ether, was meant to be converted to an 
aldehyde to perform a Nozaki–Hiyama–Kishi coupling in later steps of a total synthesis of 
Euphorbiaceae diterpenes. Compound 16 was envisaged to be prepared by a 
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hydroboration/oxidation sequence from cyclopentene 235, which was thought to be 
accessible through a RCM. Both of these steps have been key steps in the preparation of the 
cyclopentane fragment of Lentsch and Rinner.16 Imide 237 should have served as precursor 
to diene 236 in our plans. Oxidation was meant to eliminate the selenium phenyl residue 
and afford a diene, subsequent reduction was planned to provide an alcohol and protection 
to finally give 237 as product in three steps. Imide 237 was considered to be accessible 
through aldol reaction of epoxy aldehyde 238 and imide 239.  
We considered to prepare synthon 17 through the same route, starting with the enantiomer 
of epoxide 238. 
 
Scheme 36 Revised retrosynthetic analysis. 
After we found that intermediate 237 was unstable (see below) a different route (Scheme 
36) was envisaged avoiding intermediates with an epoxide moiety and an amide function in 
the same molecule. This revised route starts with aldol reaction of protected tertiary alcohol 
244 and auxiliary 239. All other steps remained the same. 
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2.2 Approach Towards Euphosalicin and Related Diterpenes 
 
Scheme 37 Preparation of chiral auxiliary 239. 
The preparation of chiral auxiliary 239 is shown in Scheme 37. Commercially available D-
phenylalanine (245) was reduced to give hydroxy amine 246. Condensation of hydroxy 
amine 246 with diethyl carbonate furnished oxazolidinone 247.78 Both of these reactions 
gave good yields. Next, oxazolidinone 247 was acylated to give imide 248 in fair yield. 
Auxiliary 239 was obtained by 1,4-addition of phenyl selenide to imide 248 in nearly 
quantitative yield. 
 
Scheme 38 Preparation of chiral epoxy aldehyde 238. 
Scheme 38 shows the preparation of chiral epoxy aldehyde 238. Commercially available 
prenyl alcohol (249) was converted to prenyl bromide (250) in good yield with PBr3.
79 
Conversion of 250 to a phosphonate and subsequent Horner-Wadsworth-Emmons 
olefination furnished ester 251 in moderate yield. Reduction of 251 with diisobutyl 
aluminum hydride gave allylic alcohol 252 in good yield. This reduction was also tried with 
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LiAlH4 and NaBH4, but no method worked as well as the reduction with diisobutyl aluminum 
hydride. Sharpless epoxidation of allylic alcohol 252 gave epoxide alcohol 253 in excellent 
yield.17 Epoxy aldehyde 238 was obtained by oxidation under Parikh-Doering conditions.18 
 
Scheme 39 Aldol reaction of epoxy aldehyde 238 and chiral auxiliary 239. 
Scheme 39 shows the aldol reaction of epoxy aldehyde 238 and chiral auxiliary 239, which 
delivered the desired product in only low yields.18 Purification of the crude product of this 
reaction was a difficult task, but via HPLC the desired product could be isolated, and 
characterized. Due to the low yield of the reaction several large scale reactions were carried 
out to provide multigram quantities of aldol adduct 237. 
 
Scheme 40 Reactions of aldol adduct 237. 
Unfortunately, no successful subsequent reaction could be performed with aldol adduct 237, 
as shown in Scheme 40. A large variety of reaction conditions (including: sodium periodate, 
hydrogen peroxide/ pyridine, hydrogen peroxide/ ammonium chloride, tributyl borane/ 
oxygen80, isobutyraldehyde/ oxygen81, tert-butyl hydroperoxide and mCPBA) were tried to 
achieve selenoxide elimination without success. The only isolated compound from these 
reactions was retro aldol product 248. 
Decomposition of aldol adduct 237 was shown after three weeks of storage at -20°C. Until 
decomposition had been observed, several of the above mentioned reactions had been 
carried out. So no clear statement can be made if the oxidation reactions may have 
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decomposed the aldol adduct 237, or if it already decomposed while storage. Interestingly a 
try to convert the imide to the corresponding alcohol led to 2-furanone 254. 
 
Scheme 41 Reactions performed with 2-furanone 254. 
As shown in Scheme 41, the primary hydroxy group of 254 was protected as PMB ether 255, 
in the next step selenoxide elimination led to intermediate 256. After derivatization of 254 
to 256 the structures of the single intermediates were easily replicable via spectroscopic 
methods. 
 
Scheme 42 Synthesis of hydroxy-γ-butyrolactones.
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Literature research led to an article82 that described rearrangement of intermediates (257) 
similar to aldol adduct 237. A generalized reaction presented in this article is shown in 
Scheme 42.  
Epoxidation of imide 260 lead directly to γ-butyrolactone 261. A mechanism proposed by 
Davies et al. is shown inScheme 43. Epoxide 262 was suggested to be built via hydroxy-
directed epoxidation. Ring-opening of the epoxide by intramolecular nucleophilic attack of 
the exocyclic carbonyl oxygen leads to the unstable iminium species 263, which may be 
stabilized by the reversible formation of N,O,O-orthoester 264. Hydrolytic workup gives 
oxazolidinone 258 and γ-butyrolactone 261. 
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Scheme 43 Proposed mechanism of the rearrangement by Davies et al.
82
 
This made clear that our aldol reaction must not include molecules having an epoxide moiety 
since intermediates generated in such a reaction would again be prone to a rearrangement. 
 
Scheme 44 Proposed epoxide free aldol reaction. 
It was envisaged that aldol adduct 243, which cannot perform the rearrangement may be a 
suitable intermediate on the route to a five-membered ring synthon. As depicted in Scheme 
44, an aldehyde containing a protected tertiary hydroxy group (244) had to be prepared. 
 
Scheme 45 TBS protection of epoxy alcohol 253. 
In order to prepare a tertiary alcohol from already prepared epoxy alcohol 253, it was 
protected as its TBS ether in excellent yield, see Scheme 45. 
 
Scheme 46 Nucleophilic opening of the epoxide.
83,84
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The next step was a nucleophilic ring opening which was tried with two different reducing 
agents, namely superhydride83 and lithium aluminum hydride84, as shown in Scheme 46. 
Both of these reactions could not furnish the desired product 266. Only starting material was 
isolated after treatment of 265 with superhydride, whereas treatment with lithium 
aluminum hydride afforded diol 267 in good yield. 
 
Scheme 47 Initially envisaged route to aldehyde 244. 
The initially envisaged route, shown in Scheme 47, would have featured a protection of the 
tertiary hydroxy group, a selective cleavage of the TBS group and an oxidation reaction to 
give the desired aldehyde 244. Unfortunately monoprotected diol 266 could not be derived 
from epoxy TBS ether 265, so the route to aldehyde 244 had to be changed. 
 
Scheme 48 Direct epoxide opening of 253. 
After epoxide opening of epoxy TBS ether 265 gave diol 267, a direct epoxide opening of 
epoxy alcohol 253 was considered. Treatment of epoxy alcohol 253 with lithium aluminum 
hydride gave expected diol 267 in low yield, as Scheme 48 shows. In comparison, epoxide 
opening after protecting with TBSCl gave a better yield of the desired material (69% over 
two steps). 
 
Scheme 49 Oxidation of diol 267.
18
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Diol 267, either from direct epoxide opening shown in Scheme 48 or from epoxide opening 
of epoxy TBS ether, was oxidized under Parikh-Doehring conditions, shown in Scheme 49, in 
good yield.18 
 
Scheme 50 PMB protection of 270. 
Table 4 PMB protection of 270. 
conditions yield 
PMB-Bundles, CSA traces 
PMB-Cl, NaH - 
PMB-Cl, NaH, TBAI - 
 
The PMB-moiety was identified as suitable protecting group. Scheme 50 and Table 4 show 
that the performed reactions did not furnish the desired product (271). Only traces of the 
PMB ether aldehyde 271 were found after HPLC, but the reaction conditions could not be 
optimized. 
 
Scheme 51 TMS protection of 270. 
Table 5 TMS protection of 270. 
conditions yield 
TMS-Cl, LDA - 
TMS-Cl, imidazole - 
TMS-OTf, 2,6-lutidine 33% 
 
Another protecting group that was considered as suitable for the aldol reaction was the 
trimethyl silyl group. The TMS-protection was carried out under different conditions as 
shown in Scheme 51 and Table 5, respectively. A reason for the low yield in the protection 
step with trimethyl silyl triflate is the competing elimination reaction which was observed. 
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Scheme 52 Attempted aldol reaction with TMS protected hydroxy aldehyde 272. 
With trimethyl silyl protected α-hydroxy aldehyde 272 in hands an aldol reaction as 
described by Barth and Roush18 was performed without success, as shown in Scheme 52. 
 
Scheme 53 Attempted aldol reaction with TBS protected hydroxy aldehyde 273. 
Scheme 53 shows that a further aldol reaction with racemic tert-butyl dimethyl silyl 
protected α-hydroxy aldehyde 273 and auxiliary 239 was unsuccessful as well. 
 
Scheme 54 Attempted aldol reaction with MOM protected hydroxy aldehyde 274. 
When racemic methoxymethyl protected α-hydroxy aldehyde 274 was tried to be reacted 
(Scheme 54) in the same manner as above, again no desired product could be isolated. 
 
Scheme 55 Attempted aldol reaction with benzaldehyde. 
In order to exclude doubts about wrong handling, the reaction was carried out with 
benzaldehyde as described in the original literature. This attempt, shown in Scheme 55, gave 
aldol adduct 275 in good yield. In literature this intermediate was not isolated, but directly 
converted to compound 276.18 
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Scheme 56 Oxidative elimination of -SePh from compund 275. 
To identify 275 as desired product of the aldol reaction, the selenyl phenyl group was 
eliminated by treatment of 275 with hydrogen peroxide and pyridine which gave 276 
(Scheme 56). The NMR data of the product of this reaction were in agreement with the data 
from the literature. 
 
Scheme 57 Intended aldol reaction of MOM protected α-hydroxy aldehyde 277 and auxiliary 239. 
The next investigations intended to perform this delicate aldol reaction with aldehyde 277, 
as shown in Scheme 57.  
 
Scheme 58 Sakurai allylation of benzyl pyruvate 279. 
Scheme 58 shows how benzyl pyruvate (279) was reacted with allyltrimethylsilane and TiCl4 
to give α hydroxy ester 280 in excellent yield, in order to prepare aldehyde 277 which is 
needed for the aldol reaction discussed above. 
 
Scheme 59 MOM protection of α-hydroxy benzyl ester 280. 
The previously prepared α-hydroxy benzyl ester (280) was protected as the corresponding 
methoxymethyl ether 281, as shown in Scheme 59, in excellent yield via a procedure that 
generates MOM-Chloride in situ.85 
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Scheme 60 Reduction of MOM protected α-hydroxy benzyl ester 281. 
The reduction of the ester moiety of methoxymethyl protected α-hydroxy benzyl ester 281 
was performed with lithium aluminum hydride, as outlined in Scheme 60, to give mono 
MOM-protected diol 282 in moderate yield. 
 
Scheme 61 Oxidation of mono MOM protected diol 282. 
As shown in Scheme 61, racemic methoxymethyl protected α-hydroxy aldehyde 277 was 
prepared by oxidation of mono methoxymethyl protected diol 282 under Parikh-Doering 
conditions in good yield. 
 
Scheme 62 Aldol reaction of MOM protected α-hydroxy aldehyde 277 and auxiliary 239. 
With racemic methoxymethyl protected α-hydroxy aldehyde 277 in hands, the aldol reaction 
as shown in Scheme 62 delivered only minor amounts of the desired material (278). 
Although this result is in disagreement with previous findings, the delicate nature of the 
aldol addition does not guarantee reproducible yields of the expected material. 
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3. Conclusion and Outlook 
The synthesis of Euphorbiaceae diterpenes has been a center of interest in many synthetic 
workgroups. Though only a handful of syntheses (see chapter 1.4.2) were reported, names 
of famous synthetic chemists are related to Euphorbiaceae diterpenes in literature. One 
reason may be the biological activities of the isolated compounds, another reason the 
challenging structures of Euphorbiaceae diterpenes. All successful approaches reported so 
far use a substituted five-membered ring synthon in early stages of the syntheses. A total of 
five independent syntheses of cyclopentane segments have been reported.  
 
Scheme 63 Aldol reaction with protected α-hydroxy aldehydes (272-274). 
Despite great effort, the flexible preparation of highly oxygenated five-membered ring 
synthons required for the preparation of various jatrophane diterpenes such as ep-7 (4), 
esulatin B (8), eup-10 (6), euphosalicin (2) or pepluanin A (3), shown in Fig. 2 (chapter 1.1 of 
this document) could not be finished in the course of this master thesis. The strategy of 
previous studies by Lentsch and Rinner16 (described in 1.4.1.5 of this document) could not be 
adapted to the highly oxygenated five membered ring synthons. The aldol reaction, which 
was in the end crucial to the failure of the synthesis, gave instable products with epoxy 
aldehyde (238). After changing the tactic, protected α-hydroxy aldehydes (272-274) were 
used instead of an epoxide, but these could not give desired aldol adducts as shown in 
Scheme 63. In comparison to the aldehydes reported as suitable by Barth18, the used 
protected α-hydroxy aldehydes (272-274) had much more steric hindrance. This could be a 
reason why the reaction was unfavored and therefore not observed. 
If it was possible to find another synthetic pathway to intermediate 243, the envisaged 
strategy could still be pursued, as outlined below. Otherwise it might be fruitful to 
reconsider the whole strategy. 
57 
 
 
Scheme 64 Route to five-membered ring synthon 18 from hypothetical aldol adduct 243. 
In Scheme 64 the synthetic route to target molecule 18 is outlined starting from inaccessible 
aldol adduct 243. This hypothetic route is based on previous synthetic work done by Lentsch 
and Rinner16. Oxidation eliminates the phenyl selenyl group, introducing an exomethylene to 
the molecule. Reduction cleaves the imide and leaves behind a primary hydroxy function. 
Selective protection of the primary hydroxy group as para-methoxy benzyl ether and 
selective protection of the secondary hydroxy group as triisopropyl silyl ether leads to diene 
242. Cyclopentene 241 is accessible through ring closing metathesis of diene 242. In the final 
step a hydroboration/oxidation protocol leads to the highly oxygenated five-membered ring 
synthon 18. 
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4. Experimental Part 
4.1 General Information 
Reactions 
All air and moisture sensitive reactions were performed in vessels dried by repeated heating 
under vacuum (heat gun) followed by purging with dry argon. Reaction procedures were 
carried out under slight overpressure of argon (balloon) in dry solvents. Sensitive reagents or 
solutions were transferred via syringe or cannula through rubber septa. 
TLC was performed on Merck silica gel 60-F254 glass plates, or on ALUGRAM Xtra SIL G/UV 
254 foil. The plates were developed with mixtures of hexane/ethyl acetate or toluene/ethyl 
acetate. UV active spots were detected at long wave UV (254 nm). Most plates were 
additionally treated with the following visualization reagent: CAN [H2SO4 (conc., 22 mL), 
phosphomolybdic acid (20 g), Ce(SO4)2 (0.5 g), 378 mL H2O)]. 
 
Solvents and Reagents 
Methylene chloride (DCM) was purified by distillation and dried by distillation from P2O5 and 
passage over aluminum oxide (aluminum oxide 90 active basic, obtained from Merck). 
Diethyl ether (Et2O) was freshly distilled from sodium/benzophenone under argon. Dimethyl 
sulfoxide (DMSO) was dried by distillation from calcium hydride under reduced pressure. 
Tetrahydrofuran (THF) was distilled from potassium under argon. Diisopropylamine (DIPA), 
diisopropylethylamine (DIPEA) and triethylamine (NEt3) were distilled from CaH2. Toluene 
was refluxed over sodium and freshly distilled. Hexane and ethyl acetate were distilled and 
used without further purification. 
 
Chromatography 
Preparative column chromatography and flash chromatography was performed with silica 
gel 60 from Merck (0.040-0.063 μm, 240-400 mesh). For HPLC separations on analytical scale 
module systems from Jasco (PU-980, UV-975 detector, RI-930 RI detector, 250 x 4 mm 
column) were used. The adsorbent was 74 Superphere Si 60 (40 μm, Merck) or Nucleosil 50 
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(4μm, Macherey-Nagel). The semipreparative and preparative scale was covered by module 
systems from Dynamax (SD-1 pump, UV-1 UV detector), Knauer (RI detector) and Shimadzu 
(LC-8A, SPD-20A UV/VIS Detector, LC-20AT Bus Module). 
 
NMR-Spectroscopy 
NMR spectra were recorded either on a Bruker Avance AV 400, DRX 400, or DRX 600 MHz 
spectrometer. All NMR spectra were measured in CDCl3 solutions and referenced to the 
residual CHCl3/CDCl3 signal (
1H, d=7.26, 13C, d=77.16). All 1H and 13C shifts are given in ppm (s 
= singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, t = triplet, q = 
quartet, m = multiplet). Coupling constants J are given in Hz. Assignments of proton 
resonances were confirmed, when possible, by correlated spectroscopy (COSY, HSQC, HMBC, 
TOCSY, NOESY). 
 
Mass Spectroscopy 
All spectra are HRMS (High Resolution Mass Spectra), these were taken with a Maxis Bruker 
spectrometer. The kind of ionization was ESI (electron spray ionization) and a TOF (time of 
flight) analyzer was used in all cases. 
 
Infrared Spectra 
IR spectra were recorded using a Bruker Vertex 70 FTIR spectrometer and are reported in 
wave numbers (cm-1). All compounds were measured using ATR (attenuated total reflection) 
sampling technique. 
 
Optical Rotation 
Optical rotation was measured on a Perkin Elmer Polarimeter 341 in combination with a 
Julabo 5 thermostat. The measured temperature is stated in all cases. The wavelength of the 
light used is 589 nm (sodium D line) in all cases. 
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4.2 Experimental Procedures 
1-Bromo-3-methylbut-2-ene79 
 
 
A solution of prenyl alcohol (249, 88 mL, 864 mmol) in 1100 mL ether was cooled to 0°C, and 
PBr3 (42.4 mL, 438 mmol) was added via dropping funnel. The solution was stirred at 0°C for 
three hours.  
Then 1000 mL saturated NaCl were added. The etheral layer was separated, dried, and 
distillated under vacuum to give prenyl bromide (250, 102 g, 79 % yield). 
 
1H NMR (400 MHz, CDCl3): δ = 5.53 (m, 1 H), 4.02 (d, J = 8.5 Hz, 2 H), 1.78 (s, 3 H), 1.73 (s, 3 
H). 
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Ethyl 5-methyl-2-methylenehex-4-enoate17 
 
 
Commercial available ethyl 2-(diethoxyphosphoryl)acetate (283, 66 mL, 333 mmol) was 
dissolved in THF (320 mL) and cooled to 0°C. Sodium hydride (9.82 g, 246 mmol) was added 
over a period of 20 min. The reaction mixture was stirred for 20 min at 0°C, then prenyl 
bromide (250, 38.0 g, 255 mmol) was added over a period of 20 min and the reaction 
mixture was stirred for six hours at room temperature.  
Afterwards, potassium carbonate (73.9 g, 535 mmol), formaldehyde (76 mL, 1.02 mol) and 
water (40.7 mL,) were added and the reaction mixture was stirred for additional two hours 
at 80°C.  
After cooling to room temperature the aqueous layer was washed twice with diethyl ether. 
The combined organic extracts were washed with water and brine, dried over magnesium 
sulfate and the solvent was removed by rotary evaporation. 
The residue was purified by column chromatography (hexane/ethyl acetate: 19/1) to give 
ethyl 5-methyl-2-methylenehex-4-enoate (251, 25.2 g, 59% yield) as a colorless liquid. 
 
1H NMR (400 MHz, CDCl3): δ = 6.11 (dd, J = 2.8, 1.6 Hz, 1 H), 5.49 (dd, J = 3.6, 2.0 Hz, 1 H), 
5.15 (m, 1 H), 4.18 (dd, J = 14.4, 7.2 Hz, 2 H), 2.96 (d, J = 7.2 Hz, 2 H), 1.71 (s, 3 H), 1.61 (s, 3 
H), 1.28 (t, J = 7.2 Hz, 3 H). 
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5-Methyl-2-methylenehex-4-en-1-ol17 
 
 
Ethyl 5-methyl-2-methylenehex-4-enoate (251, 0.203 g, 1.207 mmol) was dissolved in CH2Cl2 
(11 mL) and cooled to -78 °C. DIBAL-H (2.65 mL, 2.65 mmol, 1.0 M in heptane) was slowly 
added via syringe and the reaction mixture was stirred for two hours. 
Ethyl acetate (4.5 mL) was added dropwise to quench the reaction. Next, saturated solutions 
of NH4Cl and Rochelle salt were added (4.5 mL each) and the mixture was stirred for ten 
hours. 
The aqueous phase was extracted three times with ethyl acetate. The combined organic 
fractions were washed with H2O and brine, dried (MgSO4), and concentrated under reduced 
pressure. The residue was purified by flash chromatography (hexane/ethyl acetate: 5/1) and 
furnished 5-methyl-2-methylenehex-4-en-1-ol (252, 0.121 g) in 80% yield. 
 
1H NMR (400 MHz, CDCl3): δ = 5.14 (m, 1 H), 4.97 (d, J = 1.2 Hz, 1 H), 4.84 (d, J = 1.2 Hz, 1 H), 
4.03 (s, 2 H), 2.72 (d, J = 7.6 Hz, 2 H), 1.94 (broad s, 1 H), 1.69 (s, 3 H), 1.60 (s, 3 H).  
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(R)-(2-(3-Methylbut-2-en-1-yl)oxiran-2-yl)methanol 
 
 
Powdered 4 Å molecular sieves (1.86 g) were dispersed in CH2Cl2 (25 mL). Then, D-(-)-DIPT 
(0.131 g, 0.559 mmol) was added, and the mixture was cooled to -40 °C. After 10 min, 
titanium(IV) isopropoxide (0.142 mL, 0.485 mmol) was added, and the mixture was stirred at 
-40 °C for 15 min. After that time, 5.0-6.0 M t-BuOOH in decane (1.69 mL, 8.45 – 10.14 
mmol) was introduced, and the mixture was stirred at -40 °C for further 30 min. Then 5-
methyl-2-methylenehex-4-en-1-ol (252, 0.588 g, 4.66 mmol) in CH2Cl2 (5 mL) was added. The 
mixture was warmed to -20 °C and kept at this temperature for 12 hours. The reaction was 
quenched by addition of acetone containing 2% H2O (10 mL). After warming to room 
temperature the mixture was stirred for additional three hours. After filtering through a pad 
of celite, the filtrate was dried (MgSO4) and the solvent was removed by rotary evaporation. 
The crude product was purified by column chromatography (hexane/ethyl acetate: 9/1) to 
furnish (R)-(2-(3-methylbut-2-en-1-yl)oxiran-2-yl)methanol (253, 0.592 g, 89% yield) as a 
colorless oil. 
 
1H NMR (600 MHz, CDCl3): δ = 5.06 (t, J = 7.8 Hz, 1 H), 3.71 (d, J = 12.0 Hz, 1 H), 3.56 (d, J = 
12.0 Hz, 1 H), 2.81 (d, J = 4.8 Hz, 1 H), 2.63 (d, J = 4.2 Hz, 1 H), 2.45 (dd, J = 14.4, 7.8 Hz, 1 H), 
2.18 (dd, J = 15.6, 7.2 Hz, 2 H), 1.67 (s, 3 H), 1.58 (s, 3 H).  
13C NMR (100 MHz, CDCl3): δ = 136.4, 118.2, 63.6, 60.0, 49.6, 30.0, 26.0, 18.1. 
HRMS: [M+Na]+: calcd.: 165.0891 found: 165.0880. 
IR: ν= 3427 (br), 3051, 2970, 2918, 1449, 1378, 1232, 1104, 1043, 967, 945, 883, 843, 810, 
773, 703. 
[α]D
19,5= +41.7° 
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(S)-2-(3-Methylbut-2-en-1-yl)oxirane-2-carbaldehyde18 
 
 
A solution of sulfur trioxide-pyridine complex (1.39 g, 8.7 mmol) in DMSO (5.3 mL, 74.7 
mmol) was added over a period of 5 min to a stirred solution of (R)-(2-(3-methylbut-2-en-1-
yl)oxiran-2-yl)methanol (253, 4.49 g, 31.6 mmol) and DIPEA (4.4 mL, 25.3 mmol) in CH2Cl2 
(24.2 mL) at 0 °C. The reaction mixture was stirred for 90 min before being diluted with 11 
mL of a saturated solution of NH4Cl. The aqueous phase was separated and the organic layer 
was washed with 22 mL of a 1.0 M solution of KHSO4. 
The combined aqueous layers were extracted twice with ethyl acetate and the combined 
organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure. 
The crude product was flushed through a column filled with silica gel. (hexane/ethyl acetate: 
9/1) to give (S)-2-(3-methylbut-2-en-1-yl)oxirane-2-carbaldehyde (238, 0.517 g, 70% yield) as 
a slightly yellow oil. 
 
1H NMR (600 MHz, CDCl3): δ = 8.93 (s, 1 H), 5.05 (m, 1 H), 3.00 (dd, J = 9.3, 4.8 Hz, 2 H), 2.59 
(dd, J = 7.4 Hz, 2 H), 1.71 (s, 3 H), 1.64 (s, 3 H).  
13C NMR (100 MHz, CDCl3): δ = 199.2, 136.3, 116.3, 61.4, 48.8, 25.9, 25.7, 18.1. 
HRMS: [M+Na]+: calcd.: 163.0735 found: 163.0730. 
IR: ν= 2923, 2855, 1728, 1450, 1378, 1219, 1110, 1035, 1008, 963, 873, 861, 811, 784. 
[α]D
20= -7.0° 
 
  
65 
 
(R)-2-Amino-3-phenylpropan-1-ol78 
 
 
Boron trifluoride etherate (18.68 mL, 151 mmol) was added dropwise to a stirred solution of 
(R)-2-amino-3-phenylpropanoic acid (245, 25 g, 151 mmol) in THF (76 mL) over a period of 
30 min. The mixture was heated to reflux for two hours before the borane methyl sulfide 
complex (16.53 mL, 174 mmol) was carefully added to the refluxing solution over a period of 
100 min, afterwards the solution was again heated to reflux for 12 hours. 
The reaction mixture was cooled to ambient temperature before 23 mL of a 1:1 mixture of 
tetrahydrofuran-water was added slowly followed by 115 mL of 5 M aqueous sodium 
hydroxide. The resulting biphasic mixture was again heated to reflux for approximately 20 
hours, cooled to room temperature and filtered through a coarse fritted funnel. The residual 
solids were washed with two portions of THF (7.5 mL), and the filtrate was concentrated on 
a rotary evaporator. 
The concentrated filtrate was  extracted once with 60 mL and three times with 30 mL 
portions of CH2Cl2. Pentaerythritol was used to avoid an emulsion. The combined organic 
extracts were dried over anhydrous sodium sulfate, filtered, and concentrated by rotary 
evaporation, to give a white crystalline solid which was recrystallized from ca. 94 mL of ethyl 
acetate to give (R)-2-amino-3-phenylpropan-1-ol (246, 17.724 g, 78%)) as white needles in 
two crops. 
 
1H NMR (400 MHz, CDCl3) δ: 7.17–7.34 (m, 5 H), 3.64 (dd, J = 10.5, 4.1 Hz, 1 H,), 3.38 (dd, J 
=10.5, 7.0 Hz, 1 H), 3.12 (m, 1 H), 2.80 (dd, J =13.5, 5.3 Hz, 1 H), 2.53 (dd, J = 13.5, 8.5 Hz, 1 
H), 1.3–1.9 (broad s, 3 H). 
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(R)-4-Benzyloxazolidin-2-one78 
 
 
(R)-2-Amino-3-phenylpropan-1-ol (246, 35.45 g, 234 mmol), potassium carbonate (4.19 g, 
30.3 mmol), and diethyl carbonate (76 mL, 627 mmol) were heated to 135°C. A Vigreux 
column fitted with a distillation head and a distillation receiver was connected to the 
reaction vessel. The reaction mixture was stirred for 2.5 hours until collection of ethanol (27 
mL) in the distillation receiver was finished.  
The reaction mixture was diluted with 180 mL of CH2Cl2, and washed with 180 mL of water. 
The organic layer was dried over MgSO4 and concentrated in vacuo to afford white crystals. 
Recrystallization from 102 mL of a mixture of ethyl acetate and hexane (2/1) gave 32.596 g 
(79%) of (R)-4-(phenylmethyl)-2-oxazolidinone (247). 
 
1H NMR (400 MHz, CDCl3) δ: 7.16–7.38 (m, 5 H), 4.91 (broad s, 1 H), 4.49 (t, J = 8.3 Hz, 1 H), 
4.16 (dd, J = 8.4, 5.5 Hz, 1 H), 4.08 (m, 1 H), 2.87 (m, 2 H). 
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(R)-3-Acryloyl-4-benzyloxazolidin-2-one18 
 
 
Triethylamine (20.69 mL, 148 mmol) was added to a stirred solution of acrylic acid (5.14 mL, 
74.9 mmol) in THF (292 mL) at -25 °C. Then acryloyl chloride (6.52 mL, 80 mmol) was added 
slowly via syringe. The reaction mixture was stirred for 40 min at -20 °C. Lithium chloride 
(3.30 g, 78 mmol) was added, followed by the addition of (R)-4-benzyloxazolidin-2-one (247, 
10.0 g, 56.4 mmol). The reaction mixture was allowed to warm to room temperature and 
was stirred for further 36 h until 0.2 M HCl (117 mL) was added. The mixture was 
concentrated on the rotary evaporator and poured into ethyl acetate (235 mL). The organic 
layer was separated and the aqueous phase was extracted twice with ethyl acetate. The 
combined organic layers were washed with a saturated solution of NaHCO3 (235 mL), dried 
over Na2SO4 and concentrated under reduced pressure.  
The crude product was purified by flash column chromatography (hexane/ ethyl acetate 
gradient from 5/1 to 2/1) and re-crystallized (hexane/ethyl acetate: 8/1). (R)-3-Acryloyl-4-
benzyloxazolidin-2-one (248, 8.706 g, 67% yield) was obtained as colorless needles.  
 
1H NMR (400 MHz, CDCl3) δ: 7.52 (m, 1 H), 7.19-7.37 (m, 5 H), 6.61, (dd, J = 17.1, 1.8 Hz, 1 H), 
5.94 (dd, J = 10.3, 1.8 Hz, 1 H), 4.75 (m, 1 H), 4.22 (m, 2 H), 3.36 (dd, J = 13.4, 3.5 Hz, 1 H), 
2.82 (dd J = 13.5, 9.5 Hz, 1 H). 
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(R)-4-Benzyl-3-(3-(phenylselanyl)propanoyl)oxazolidin-2-one18 
 
 
NaBH4 (2.71 g, 71.7 mmol) was added in small portions to a stirred suspension of diphenyl 
diselenide (10.73 g, 34.4 mmol) in ethanol (295 mL) at room temperature over 10 min. After 
stirring for 5 min, acetic acid (3.11 mL, 54.3 mmol) was added dropwise and stirring was 
continued for 5 min. This prepared reaction mixture was then added slowly to a vigorously 
stirred solution of (R)-3-acryloyl-4-benzyloxazolidin-2-one (248, 13.05 g, 56.4 mmol) in THF 
(191 mL) at -35 °C with a cannula over 15 min. After complete addition the reaction mixture 
was allowed to warm to -20 °C over a period of 40 min.  
The reaction was quenched by addition of a saturated solution of NH4Cl (240 mL) and the 
resulting mixture was poured into CH2Cl2 (690 mL). The organic phase was separated and the 
aqueous phase was extracted three times with CH2Cl2. The combined organic extracts were 
dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting yellow 
solid was recrystallized from 170 mL hexane and 6.9 mL dichloromethane. The solid product 
was filtered, washed twice with cold hexane and dried under vacuum to give (R)-4-benzyl-3-
(3-(phenylselanyl)propanoyl)oxazolidin-2-one (239, 21.901 g, 100% yield) as white crystals. 
 
1H NMR (400 MHz, CDCl3) δ = 7.55 (m, 2 H), 7.17 – 7.35 (m, 8 H), 4.66 (m, 1 H), 4.20 (m, 2 H,), 
3.41 (m, 2 H,), 3.29 (dd, J = 13.4, 3.3 Hz, 1 H,), 3.19 (t, J = 6.9 Hz, 2 H,), 2.78 (dd, J = 13.3, 9.6 
Hz, 1 H,). 
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(R)-4-Benzyl-3-((2R,3R)-3-hydroxy-3-((S)-2-(3-methylbut-2-en-1-yl)oxiran-2-yl)-
2-((phenylselanyl)methyl)propanoyl)oxazolidin-2-one18 
 
 
Dibutylboron triflate (1.0 M, 5.73 mL, 5.7 mmol) was slowly added to a stirred solution of 
(R)-4-benzyl-3-(3-(phenylselanyl)propanoyl)oxazolidin-2-one (239, 1.62 g, 4.2 mmol) in 
CH2Cl2 (9.8 mL) at -78°C. The mixture was stirred for 10 min before NEt3 (1.47 mL, 10.6 
mmol) was added dropwise. After stirring at -78°C for 75 min, the mixture was warmed to 
0°C. After 15 min, the solution was re-cooled to -78°C before freshly prepared (S)-2-(3-
methylbut-2-en-1-yl)oxirane-2-carbaldehyde (238, 0.60 g, 4.3 mmol) in CH2Cl2 (2.7 mL) was 
added slowly. The reaction mixture was stirred at -78 °C for five hours and allowed to warm 
to room temperature over a period of 12 hours before being quenched with 40 mL of a 
saturated solution of NH4Cl. The organic layer was separated and the aqueous phase was 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and solvents 
were removed on the rotary evaporator. The crude product was purified by flash column 
chromatography (hexane/ ethyl acetate gradient from 19/1 to 2/1) to give (R)-4-benzyl-3-
((2R,3R)-3-hydroxy-3-((S)-2-(3-methylbut-2-en-1-yl)oxiran-2-yl)-2-
((phenylselanyl)methyl)propanoyl)oxazolidin-2-one(237, 0.418 g, 19% yield). 
 
1H NMR (400 MHz, CDCl3): δ = 7.53-7.63 (m, 2 H), 7.26-7.38 (m, 8 H), 5.23 (m, 1 H), 4.39 (m, 1 
H), 4.31 (d, J =6.4 Hz, 1 H), 4.2 (t, J = 8.8 Hz, 1 H), 4.08 (dd, J = 8.9, 6.5 Hz, 1 H), 3.97 (dd, J = 
3.1, 1.5 Hz, 1 H), 3.66 (dd, J =12.3, 3.8 Hz, 1 H), 3.45 – 3.51 (m, 2 H), 2.86 (dt, J = 12.8, 3.5 Hz, 
1 H), 2.74 (dd, J = 13.5, 10.2 Hz, 1 H), 2.58 (d, J =7.6 Hz, 2 H), 2.47 (t, J =12.5 Hz, 1 H), 1.76 (s, 
3 H), 1.65 (s, 3 H). 
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5-(Hydroxymethyl)-5-(3-methylbut-2-en-1-yl)-3-((phenylselanyl)methyl)furan-
2(5H)-one86 
 
 
A solution of (R)-4-benzyl-3-((2R,3R)-3-hydroxy-3-((S)-2-(3-methylbut-2-en-1-yl)oxiran-2-yl)-
2-((phenylselanyl)methyl)propanoyl)oxazolidin-2-one (237, 98 mg, 0.18 mmol) in THF (5.1 
mL) was cooled to -20°C. MeOH (7 µL, 0.18 mmol) and 2 M LiBH4 solution (0.37 mL, 0.74 
mmol) were added subsequently. The mixture was stirred for one hour at -20°C. The 
reaction was quenched by addition of saturated ammonium chloride solution. The aqueous 
layer was extracted three times with diethyl ether (10 mL). The combined organic layers 
were dried over Na2SO4 and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography (hexane/ ethyl acetate gradient from 5/1 to 3/1) to 
give 5-(hydroxymethyl)-5-(3-methylbut-2-en-1-yl)-3-((phenylselanyl)methyl)furan-2(5H)-one 
(254, 14 mg, 22% yield). 
 
1H NMR (400 MHz, CDCl3): δ = 7.49-7.53 (m, 2 H), 7.27-7.29 (m, 3 H), 6.69 (s, 1 H) 4.85 (m, 1 
H), 3.66 (d, J = 11.7 Hz, 1 H), 3.65 (t, J = 1.3 Hz, 2 H), 3.53 (d, J = 11.7 Hz, 1 H), 2.38 (m, 2 H), 
1.66 (s, 3 H), 1.55 (s, 3 H). 
HRMS: [M+Na]+: calcd.: 375.0475 found: 375.0486. 
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5-(((4-Methoxybenzyl)oxy)methyl)-5-(3-methylbut-2-en-1-yl)-3-
((phenylselanyl)methyl)furan-2(5H)-one 
 
 
Camphorsulfonic acid (1 mg) was added to a solution of 5-(hydroxymethyl)-5-(3-methylbut-
2-en-1-yl)-3-((phenylselanyl)methyl)furan-2(5H)-one (254, 19 mg, 0.05 mmol) and 4-
methoxybenzyl 2,2,2-trichloroacetimidate (0.1 mL, 0.12 mmol) in CH2Cl2 (1 mL). The reaction 
mixture was stirred for 12 h at room temperature. Though complete consumption of the 
starting materials could not be observed, the reaction was quenched with a saturated 
solution of sodium bicarbonate. The aqueous layer was extracted with DCM three times. The 
combined organic layers were dried over MgSO4 and solvent was removed via rotary 
evaporation. The crude product was purified by flash column chromatography (hexane/ 
ethyl acetate gradient from 9/1 to 3/1) to give 5-(((4-methoxybenzyl)oxy)methyl)-5-(3-
methylbut-2-en-1-yl)-3-((phenylselanyl)methyl)furan-2(5H)-one (255, 11 mg, 42% yield). 
 
1H NMR (400 MHz, CDCl3): δ = 7.47-7.50 (m, 2 H), 7.28-7.32 (m, 3 H), 6.85-6.92 (m, 4 H), 6.78 
(s, 1 H), 4.86 (m, 1 H), 4.40 (s, 2 H), 3.82 (s, 3 H), 3.65 (s, 2 H), 3.47 (d, J = 10.1 Hz, 1 H), 3.34 
(d, J = 10.1 Hz, 1 H), 2.37 (m, 2 H), 1.64 (s, 3 H), 1.54 (s, 3 H). 
HRMS: [M+Na]+: calcd.: 495.1051 found: 495.1054. 
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4-Hydroxy-5-(((4-methoxybenzyl)oxy)methyl)-5-(3-methylbut-2-en-1-yl)-3-
methylenedihydrofuran-2(3H)-one18 
 
 
To a stirred solution of 5-(((4-methoxybenzyl)oxy)methyl)-5-(3-methylbut-2-en-1-yl)-3-
((phenylselanyl)methyl)furan-2(5H)-one (255, 10 mg, 0.02 mmol) and pyridine ( 1µL, 
0.01mmol) in CH2Cl2 (0.2 mL) was added hydrogen peroxide (30%, 3.5 µl, 0.03mmol) at 0°C. 
The mixture was stirred for 30 min at 0°C, and additional 90 min at room temperature. Then, 
2 mg Na2SO3 were added and the aqueous layer was extracted with DCM three times. The 
combined organic layers were washed three times with water, dried over MgSO4 and 
concentrated through rotary evaporation. Purification by flash column chromatography 
(hexane/ ethyl acetate 5/1) gave 4-hydroxy-5-(((4-methoxybenzyl)oxy)methyl)-5-(3-
methylbut-2-en-1-yl)-3-methylenedihydrofuran-2(3H)-one (256, 1 mg, 14% yield). 
 
1H NMR (400 MHz, CDCl3): δ = 7.16 (d, J = 8.6 Hz, 2 H), 6.87 (d, J = 8.6 Hz, 2 H), 6.31 (d, J = 2.7 
Hz, 1 H), 5.82 (d, J = 2.7 Hz, 1 H), 5.15 (m, 1 H), 4.56 (dt, J = 11.2, 2.7 Hz, 1 H), 4.49 (d, J =11.5 
Hz, 1 H), 4.39 (d, J =11.5 Hz, 1 H), 3.83 (d, J = 10.6 Hz, 1 H), 3.81 (s, 3 H), 3.59 (d, J = 10.6 Hz, 1 
H), 3.09 (d, J = 10.9 Hz, 1 H), 2.39 (d, J =7.4 Hz, 2 H), 1.72 (s, 3 H), 1.64 (s, 3 H). 
HRMS: [M+Na]+: calcd.: 355.1521 found: 355.1520. 
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(S)-Tert-butyldimethyl((2-(3-methylbut-2-en-1-yl)oxiran-2-yl)methoxy)silane 
 
 
Imidazole (0.124 g, 1.83 mmol) was added to a solution of (R)-(2-(3-methylbut-2-en-1-
yl)oxiran-2-yl)methanol (253, 0.13 g, 0.91 mmol) in CH2Cl2 (1.3 mL) at 0°C. Then, TBSCl (0.152 
g, 1.01 mmol) was added. 
After complete consumption of the starting materials as indicated by TLC, a saturated 
solution of NH4Cl was added and the aqueous layer was extracted with CH2Cl2 twice. The 
combined organic layers were dried over MgSO4 and concentrated on the rotary evaporator. 
The crude product was purified by flash column chromatography (hexane/ ethyl acetate: 
40/1) to give (S)-tert-butyldimethyl((2-(3-methylbut-2-en-1-yl)oxiran-2-yl)methoxy)silane 
(265, 0.208 g, 89% yield). 
 
1H NMR (400 MHz, CDCl3): δ =5.12 (m, 1 H), 3.65 (dd, J = 23.0, 11.2 Hz, 2 H), 2.69 (d, J = 5.1 
Hz, 1 H), 2.61 (d, J = 5.1 Hz, 1 H), 2.48 (dd, J = 15.5, 8.0 Hz, 1 H), 2.26 (dd, J = 15.5, 8.0 Hz, 1 
H), 1.71 (s, 3 H), 1.62 (s, 3 H), 0.90 (s, 9 H), 0.06 (s, 3 H), 0.05 (s, 3 H). 
13C NMR (100 MHz, CDCl3): δ =132.8, 118.4, 66.0, 65.3, 49.6, 30.3, 29.0, 26.0, 25.9, 17.5, -5.3. 
HRMS: [M+Na]+: calcd.: 279.1756 found: 279.1749. 
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(R)-2,5-Dimethylhex-4-ene-1,2-diol84 
 
 
To a stirred suspension of LiAlH4 (58 mg, 1.54 mmol) in dry THF (2.7 mL) was added a 
solution of of (S)-tert-butyldimethyl((2-(3-methylbut-2-en-1-yl)oxiran-2-yl)methoxy)silane 
(265, 0.789 g, 3.08 mmol) in dry THF (2.7 mL) and the mixture was stirred for 2 h. After TLC 
showed incomplete consumption of the starting material further LiAlH4 (0.058 g, 1.54 mmol) 
was added. 
 After TLC showed complete consumption of the starting material, excess LiAlH4 was 
destroyed by addition of saturated potassium sodium tartrate, and the mixture was 
extracted with ethyl acetate. The organic layer was washed with brine, dried over MgSO4, 
and concentrated on the rotary evaporator. The residue was purified by flash column 
chromatography (hexane/ ethyl acetate: 3/1) yielding(R)-2,5-dimethylhex-4-ene-1,2-diol 
(267, 0.345 g, 78%). 
 
1H NMR (400 MHz, CDCl3): δ =5.15 (m, 1 H), 3.38 (dd, J = 25.1, 10.9 Hz, 2 H), 2.76 (broad s, 1 
H), 2.49 (broad s, 1 H), 2.16 (m, 2 H), 1.68 (s, 3 H), 1.59 (s, 3 H), 1.09 (s, 3 H). 
13C NMR (100 MHz, CDCl3): δ = 135.6, 118.8, 73.4, 69.0, 36.7, 25.5, 22.4, 17.2. 
HRMS: [M+Na]+: calcd.: 167.1048 found: 167.1037. 
IR: ν= 3375 (br), 2971, 2925, 2861, 1452, 1378, 1130, 1051, 904, 849, 766. 
[α]D
19,5= +6.6° 
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(R)-2,5-Dimethylhex-4-ene-1,2-diol84 
 
 
To a suspension of LiAlH4 (0.676 g, 17.82 mmol) in dry THF (31 mL) was added a solution of 
(R)-(2-(3-methylbut-2-en-1-yl)oxiran-2-yl)methanol (253, 5.000 g, 35.6 mmol) in dry THF (31 
mL) and the mixture was stirred for 2 h. Excess LiAlH4 was destroyed by addition of saturated 
potassium sodium tartrate, and the mixture was extracted with ethyl acetate. The organic 
layer was washed with brine, dried over MgSO4, and concentrated on the rotary evaporator. 
The residue was purified by flash column chromatography (hexane/ ethyl acetate: 1/1) 
yielding(R)-2,5-dimethylhex-4-ene-1,2-diol (267, 2.110 g 41% yield). 
 
1H NMR (400 MHz, CDCl3): δ =5.15 (m, 1 H), 3.38 (dd, J = 25.1, 10.9 Hz, 2 H), 2.76 (broad s, 1 
H), 2.49 (broad s, 1 H), 2.16 (m, 2 H), 1.68 (s, 3 H), 1.59 (s, 3 H), 1.09 (s, 3 H). 
13C NMR (100 MHz, CDCl3): δ = 135.6, 118.8, 73.4, 69.0, 36.7, 25.5, 22.4, 17.2. 
HRMS: [M+Na]+: calcd.: 167.1048 found: 167.1037. 
IR: ν= 3375 (br), 2971, 2925, 2861, 1452, 1378, 1130, 1051, 904, 849, 766. 
[α]D
19,5= +6.6° 
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(R)-2-Hydroxy-2,5-dimethylhex-4-enal87 
 
 
To a solution of (R)-2,5-dimethylhex-4-ene-1,2-diol (267, 3.102 g, 14.65 mmol) in DCM 
(83 mL), DMSO (3.64 mL, 51.3 mmol), Et3N (7.15 mL, 51.3 mmol) and pyridine sulfur trioxide 
(5.84 g, 36.7 mmol) were added at 0 °C and the reaction mixture was stirred at 0 °C for 3 
hours. The solution was poured into sat. NH4Cl, the organic layer was separated and the 
aqueous phase was extracted twice with diethyl ether. The combined organic layers were 
subsequently washed with water and brine, dried over anhydrous MgSO4 and concentrated 
on the rotary evaporator. The crude product was purified by flash column chromatography 
(hexane/ ethyl acetate gradient from 9/1 to 5/1) to give (R)-2-hydroxy-2,5-dimethylhex-4-
enal (270, 1.60 g, 77% yield). 
 
1H NMR (400 MHz, CDCl3): δ =9.54 (s, 1 H), 5.08 (m, 1 H), 3.03 (broad s, 1 H), 2.39 (m, 2 H), 1 
H), 1.72 (s, 3 H), 1.64 (s, 3 H), 1.33 (s, 3 H). 
13C NMR (100 MHz, CDCl3): δ = 204.3, 136.8, 116.1, 78.4, 36.2, 26.4, 22.4, 17.8. 
HRMS: [2M+Na]+: calcd.: 307.1885 found: 307.1892. 
IR: ν= 3457 (br), 2971, 2925, 2857, 2339, 1734, 1456, 1376, 1217, 1092, 806. 
[α]D
20= -29.1° 
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(R)-2,5-Dimethyl-2-((trimethylsilyl)oxy)hex-4-enal 
 
 
2,6-Lutidine (0.65 mL, 5.57 mmol) was added to a solution of (R)-2-hydroxy-2,5-dimethylhex-
4-enal (270, 0.501 g, 2.78 mmol) in DCM (2.78 mL), followed by TMS-OTf (0.755 mL, 4.18 
mmol). As the reaction did not proceed to completion additionally 0.13 mL TMS-OTf (0.696 
mmol) and 0.16 mL 2,6-lutidine (1.392 mmol) were added. 
The reaction was quenched with NH4Cl and the aqueous layer was washed with DCM twice. 
The combined organic layers were washed with water and brine, and dried over Na2SO4. 
Solvents were removed under reduced pressure and the residue was purified by flash 
chromatography (hexane/ethyl acetate: 19/1) to furnish (R)-2,5-dimethyl-2-
((trimethylsilyl)oxy)hex-4-enal (272, 0.191 g, 33% yield). 
 
1H NMR (400 MHz, CDCl3): δ = 9.53 (s, 1 H), 5.11 (m, 1 H), 2.30 (m, 2 H), 1.71 (s, 3 H), 1.60 (s, 
3 H), 1.27 (s, 3 H), 0.17 (s, 9 H). 
13C NMR (100 MHz, CDCl3): 204.7, 134.4, 117.5, 80.9, 37.2, 25.1, 21.9, 18.0, 2.3. 
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(R)-2-((4-Methoxybenzyl)oxy)-2,5-dimethylhex-4-enal 
 
 
CSA (1 mg) was added to a solution of (R)-2-hydroxy-2,5-dimethylhex-4-enal (270, 0.033 g, 
0.231 mmol) and 4-methoxybenzyl 2,2,2-trichloroacetimidate (1.0 M, 0.255 mL, 0.255 mmol) 
in CH2Cl2 (4.3 mL). The reaction mixture was stirred for 13 hours at 50°C in a sealed tube. 
Because TLC showed incomplete consumption of the starting material further 0.231 mL 4-
methoxybenzyl 2,2,2-trichloroacetimidate (1.0 M, 0.231 mmol) were added, but, despite 
further addition, complete consumption of the starting materials could not be observed. The 
reaction was quenched with sat. NaHCO3. The aqueous layer was extracted with DCM. The 
combined organic layers were dried over Na2SO4, and concentrated on the rotary 
evaporator. Purification of the crude material via HPLC could only give a non-quantifying 
trace of (R)-2-((4-methoxybenzyl)oxy)-2,5-dimethylhex-4-enal (271). 
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Benzyl 2-hydroxy-2-methylpent-4-enoate 
 
 
Titanium(IV) chloride (2.98 mL, 27.0 mmol) was slowly added to a solution of benzyl 2-
oxopropanoate (279, 4.81 g, 27.0 mmol) in DCM (56 mL) in a three-necked 250 mL flask, 
which was cooled via a methanol/CO2 cooling bath to -80°C. Allyltrimethylsilane (10.12 mL, 
63.4 mmol) in DCM (56 mL) was added drop wise over a period of 30 min. The reaction 
mixture was stirred for 30 min at -80°C. 
After complete consumption of the starting material as indicated by TLC, 70 mL of water 
were added. The aqueous layer was washed three times with 25mL diethyl ether. The 
combined organic layers were dried over MgSO4 and the solvents were removed in vacuo. 
Flash chromatography (hexane/ethyl acetate gradient from 19:1 to 9:1) of the crude product 
furnished benzyl 2-hydroxy-2-methylpent-4-enoate (280, 5.326 g, 90% yield). 
 
1H NMR (400 MHz, CDCl3): 7.31-7.42 (m, 5 H), 5.74 (m, 1 H), 5.19 (s, 2 H), 5.06 (m, 2 H), 3.11 
(s, 1 H), 2.52 (dd, J = 14.1, 7.3 Hz, 1 H), 2.40 (dd, J = 14.1, 7.3 Hz, 1 H), 1.44 (s, 3 H). 
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Benzyl 2-(methoxymethoxy)-2-methylpent-4-enoate85 
 
 
Zinc bromide (0.019 g, 0.084 mmol) was added to a solution of dimethoxymethane (8.62 mL, 
96 mmol) in DCM (10.4 mL). The reaction mixture was stirred until ZnBr2 was dissolved, then 
acetyl chloride (6.84 mL, 96 mmol) was added via dropping funnel over a period of 15 min. 
The exothermic reaction warmed slowly to 40-45 °C and re-cooled to ambient temperature 
over a period of three hours. Afterwards the purity and conversion was determined by NMR 
spectroscopy. This solution of MOMCl was used in the next step without further 
manipulation in the next step. 
First benzyl 2-hydroxy-2-methylpent-4-enoate (280, 5.3 g, 24.06 mmol) was added via 
syringe, then DIPEA (33.6 mL, 192 mmol) was added to the reaction mixture dropwise via 
the addition funnel over a period of 30 min at 0°C. The reaction mixture was allowed to 
warm to ambient temperature and was stirred for 12 h.  
After dilution with ethyl acetate and addition of saturated NH4Cl solution the biphasic 
mixture was stirred vigorously for 15 minutes. The aqueous layer was washed with three 
times with DCM and twice with ethyl acetate. The combined organic layers were washed 
with water and brine, dried over MgSO4 and concentrated under reduced pressure. The 
resulting crude product was purified by flash column chromatography (hexane/ethyl 
acetate: 9/1) to give benzyl 2-(methoxymethoxy)-2-methylpent-4-enoate (281, 5.66 g, 89% 
yield). 
 
1H NMR (400 MHz, CDCl3): 7.29-7.39 (m, 5 H), 5.77 (m, 1 H), 5.15 (s, 2 H), 5.06 (m, 2 H), 4.76 
(dd, J = 12.3, 7.3 Hz, 2 H), 3.35 (s, 3 H), 2.55 (m, 2 H), 1.48 (s, 3 H). 
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2-(Methoxymethoxy)-2-methylpent-4-en-1-ol 
 
 
Benzyl 2-(methoxymethoxy)-2-methylpent-4-enoate (281, 9.65 g, 36.5 mmol) inTHF (105 mL) 
was added to a stirred solution of LiAlH4 (0.915 g, 24.10 mmol) in THF (89 mL). The reaction 
mixture was heated to 70°C. 
After TLC showed complete consumption of the starting materials, 11 mL aqueous KOH (10 
w%) were added at 0°C. The mixture was stirred for 12 hours, filtered through Celite, and 
dried over MgSO4. After rotary evaporation the crude product was purified by flash 
chromatography (toluene/ethyl acetate: 19:1) to give 2-(methoxymethoxy)-2-methylpent-4-
en-1-ol (282, 3.653 g, 62% yield). 
 
1H NMR (400 MHz, CDCl3): 5.82 (m, 1 H), 5.10 (m, 2 H), 5.06 (m, 2 H), 4.74 (dd, J = 10.1, 7.5 
Hz, 2 H), 3.45 (m, 2 H), 3.43 (s, 3 H) 2.33 (m, 2 H), 1.17 (s, 3 H). 
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2-(Methoxymethoxy)-2-methylpent-4-enal87 
 
 
2-(methoxymethoxy)-2-methylpent-4-en-1-ol (282, 1 g, 6.24 mmol) was dissolved in DCM 
(35 mL), then DMSO (1.6 mL, 21.9 mmol), Et3N (3.0 mL, 21.9 mmol) and pyridine sulfur 
trioxide (2.49 g, 15.7 mmol) were added at 0 °C. The reaction mixture was stirred at 0 °C for 
three hours until it was poured into sat NH4Cl (4 mL). The organic layer was separated and 
the aqueous layer was extracted with diethyl ether. The combined organic layers were 
washed with water and brine, dried over MgSO4 and concentrated under reduced pressure. 
Purification of the crude product by flash chromatography (hexane/ ethyl acetate gradient 
from 9/1 to 5/1) gave 2-(methoxymethoxy)-2-methylpent-4-enal (277, 0.764 g, 77% yield). 
 
1H NMR (400 MHz, CDCl3): 9.55 (s, 1 H) 5.78 (m, 1 H), 5.14 (m, 2 H), 4.76 (d, J = 7.3 Hz, 1 H), 
4.70 (d, J = 7.3 Hz, 1 H), 3.41 (m, 3 H), 2.48 (dd, J = 14.4, 7.1 Hz, 1 H), 2.37 (dd, J = 14.4, 7.1 
Hz, 1 H), 1.29 (s, 3 H). 
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(4R)-4-Benzyl-3-(3-hydroxy-3-phenyl-2-
((phenylselanyl)methyl)propanoyl)oxazolidin-2-one18 
 
 
Dibutylboron triflate (3.18 mL, 3.18 mmol, 1.0 M solution in CH2Cl2) was added slowly to a 
solution of (R)-4-Benzyl-3-(3-(phenylselanyl)propanoyl)oxazolidin-2-one (239, 0.900 g, 2.318 
mmol) in CH2Cl2 (5. 5 mL) at -78 °C. The mixture was stirred for 10 min, then NEt3 (0.82 mL, 
5.86 mmol) was added drop wise. The resulting mixture was stirred at -78 °C for 75 min, 
then warmed to 0 °C for 15 min, before it was recooled to -78 °C. A solution of freshly 
distilled benzaldehyde (0.24 mL, 2.38 mmol) in CH2Cl2 (1.5 mL) was added slowly in two 
portions. The reaction mixture was slowly warmed from -78°C to 0°C over a period of 13 
hours and warmed to 40°C for additional 2 hours. After addition of 5 mL NH4Cl the organic 
layer was separated and the aqueous phase was extracted with CH2Cl2 three times. The 
combined organic layers were dried over Na2SO4 and solvents were removed on the rotary 
evaporator. The crude product was purified through flash chromatography (hexane/ ethyl 
acetate gradient from 5:1 to 1:1) to give (4R)-4-benzyl-3-(3-hydroxy-3-phenyl-2-
((phenylselanyl)methyl)propanoyl)oxazolidin-2-one (275, 0.294 g, 79%). 
 
1H NMR (400 MHz, CDCl3): 7.18 – 7.39 (m, 15 H), 5.05 (m, 1 H), 4.70 (m, 1 H), 4.49 (m, 1 H), 
4.05 (dd, J = 8.9, 2.5 Hz, 1 H), 3.87 (t, J = 8.5 Hz, 1 H), 3.41 (dd, J = 12.4, 10.6 Hz, 1 H), 3.23 (m, 
2 H), 2.72 (dd, J = 13.6, 9.7 Hz, 1 H). 
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(4R)-4-Benzyl-3-(2-(hydroxy(phenyl)methyl)acryloyl)oxazolidin-2-one18 
 
 
To a solution of (4R)-4-benzyl-3-(3-hydroxy-3-phenyl-2-
((phenylselanyl)methyl)propanoyl)oxazolidin-2-one (275, 0.968 g, 1.96 mmol) in CH2Cl2 (9.8 
mL) was added pyridine (0.32 mL, 3.92 mmol) followed by the addition of hydrogen peroxide 
(30%, 0.62 mL, 6.07 mmol) and the reaction mixture was stirred vigorously at room 
temperature. As TLC showed incomplete consumption of the starting material an additional 
amount of hydrogen peroxide (0.30 mL, 2.94 mmol) was added. The reaction mixture was 
poured into aqueous layer of ChDa-128 (preparation of (4R)-4-benzyl-3-(3-hydroxy-3-phenyl-
2-((phenylselanyl)methyl)propanoyl)oxazolidin-2-one (275)). The organic layer was extracted 
twice with DCM. The combined organic layers were dried over Na2SO4 and concentrated on 
the rotary evaporator. The crude product was purified by flash chromatography 
(hexane/ethyl acetate gradient from 5/1 to 1/1) and recrystallization (hexane/ethyl acetate 
1:1) to give (4R)-4-benzyl-3-(2-(hydroxy(phenyl)methyl)acryloyl)oxazolidin-2-one (276, 0.260 
g, 40 % yield). 
 
1H NMR (400 MHz, CDCl3): 7.27 – 7.46 (m, 8 H), 7.13 – 7.17 (m, 2 H), 5.61 (m, 1 H) 5.59 (m, 2 
H), 4.67 (m, 2 H), 4.21 (m, 2 H), 3.21 (dd, J = 13.6, 3.4 Hz, 1 H), 3.12 (d, J = 5.3 Hz, 1 H), 2.73 
(dd, J = 13.6, 9.2 Hz, 1 H). 
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(4R)-4-Benzyl-3-(3-hydroxy-4-(methoxymethoxy)-4-methyl-2-
((phenylselanyl)methyl)hept-6-enoyl)oxazolidin-2-one18 
 
 
Dibutylboron triflate (3.63 mL, 3.63 mmol, 1.0 M solution in CH2Cl2) was added slowly to a 
solution of (R)-4-Benzyl-3-(3-(phenylselanyl)propanoyl)oxazolidin-2-one (239, 1.029 g, 2.65 
mmol) in CH2Cl2 (6.9 mL) at -78 °C. The mixture was stirred for 10 min, then NEt3 (0.93 mL, 
6.70 mmol) was added drop wise. The resulting mixture was stirred at -78 °C for 75 min, 
then at 0 °C for 15 min and afterwards it was re-cooled again to -78 °C. A solution of freshly 
prepared 2-(methoxymethoxy)-2-methylpent-4-enal (277, 0.429 g, 2.71 mmol) in CH2Cl2 (1 
mL) was added slowly in two portions via syringe. The reaction mixture was slowly warmed 
from -78°C to 12°C over a period 14 hours. Then, the reaction was quenched with NH4Cl and 
the aqueous layer was washed with CH2Cl2 three times. The combined organic layers were 
dried over Na2SO4 and concentrated on the rotary evaporator. 
Purification via flash column chromatography (hexane/ethyl acetate: 2/1) furnished (4R)-4-
benzyl-3-(3-hydroxy-4-(methoxymethoxy)-4-methyl-2-((phenylselanyl)methyl)hept-6-
enoyl)oxazolidin-2-one (278, 7.4 mg, 1% yield). 
 
1H NMR (400 MHz, CDCl3): 7.56 – 7.59 (m, 2 H), 7.23 – 7.35 (m, 8 H), 5.74 (m, 1 H), 5.08 (m, 2 
H), 4.68 (m, 2 H), 4.17 (m, 2 H), 3.86 (m, 1 H), 3.44 (m, 2 H), 3.35 (s, 3 H), 3.26 (m, 2 H), 3.09 
(d, J = 9.0 Hz, 1 H), 2.75 (dd, J = 13.5, 9.9 Hz, 1 H), 2.44 (m, 2 H), 1.14 (s, 3 H). 
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Abstract  
The spurge family (Euphorbiaceae) is phytopharmacologically important since ancient times. 
A broad range of biological activities have been reported for plant extracts. Particularly, 
jatrophane diterpenes are potent P-glycoprotein modulators. Efflux pumps, such as P-
glycoprotein, are responsible for multidrug resistance (MDR) effects of cancer cells which 
might result in the failure of cancer chemotherapy. Thus, jatrophane diterpenes are 
considered as co-therapuetics in cancer chemotherapy. 
Several synthetic studies have been reported so far because of the fascinating structures and 
the promising biological activities. However, only few total syntheses of natural jatrophane 
diterpenes and non-natural jatrophane diterpenes were reported.  
Within this thesis the synthetic efforts towards highly oxygenated five-membered ring 
synthons are reported. The route is based on previous studies on less oxygenated 
cyclopentane derivatives from our laboratory. Key steps are a Sharpless asymmetric 
epoxidation, an aldol reaction, a ring closing metathesis and a hydroboration/oxidation 
sequence. 
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Zusammenfassung 
Die Wolfsmilchgewächse (Euphorbiaceae), sind seit jeher phytopharmakologisch von großer 
Bedeutung. Extrakte von Wolfsmilchgewächsen besitzen verschiedenste biologische 
Aktivitäten. Effluxpumpen, wie P-Glykoprotein, sind verantwortlich für multidrug resistance 
(MDR) Effekte, die zum Scheitern von Chemotherapie bei Krebserkrankungen führen. 
Nachdem in Untersuchungen von Jatrophan Diterpenen die Inhibierung solcher 
Effluxpumpen erreicht werden konnte ist es denkbar Jatrophan Diterpene in 
Chemotherapien zu verwenden um MDR Effekten vorzubeugen. 
Dass bereits einige Synthesearbeiten publiziert wurden lässt sich auf die faszinierenden 
Strukturen und vielversprechenden biologischen Aktivitäten von Jatrophanen zurückführen. 
Darüber hinaus wurden auch einige wenige Totalsynthesen, sowohl von natürlichen als auch 
unnatürlichen Jatrophan Diterpenen mit Jatrophan Struktur, veröffentlicht. 
In dieser Masterarbeit sind die synthetischen Arbeiten an höher oxygenierten fünfgliedrigen 
Syntheseintermediaten dokumentiert. Der gewählte Syntheseweg orientiert sich stark an 
vorhergehenden synthetischen Arbeiten an weniger oxygenierten fünfgliedrigen 
Ringfragmenten, die in unserer Arbeitsgruppe durchgeführt wurden. Geplante 
Schlüsselschritte der Synthese umfassen unter anderem eine asymmetrische Epoxidierung 
nach Sharpless, eine Aldol Reaktion, eine Ringschlussmetathese sowie einer Sequenz aus 
einer Hydroborierung und einer Oxidation. 
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